{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T14:56:53Z","timestamp":1795013813706,"version":"4.9.1"},"reference-count":545,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ulcerative colitis (UC) is the most common chronic inflammatory disease of the intestinal tract in clinical practice, and long-term chronic inflammation leads to repeated damage to and repair of the colonic mucosa, which may progress to malignancy through atypical hyperplasia. However, there are currently no fully targeted drugs for the treatment of UC. In this review, we discuss several cellular processes, such as autophagy, endoplasmic reticulum stress, mitochondrial dysfunction, macrophage polarization, ferroptosis and the Th\/Treg cell balance, which are associated with the occurrence and development of UC. Many molecular targets and signaling pathways, such as nuclear factor kappa-B (NF-\u03baB), phosphatidylinositol 3 kinase\/protein kinase B (PI3K\/AKT), Wnt\/\u03b2-catenin, adenosine 5\u2019-monophosphate-activated protein kinase (AMPK), toll-like receptor (TLR), Janus kinase\/signal transducer and activator of transcription (JAK\/STAT), long noncoding RNAs (lncRNAs), and microRNAs (miRNAs), play crucial roles in the progression of UC. We also summarize the common treatment strategies for UC, including lifestyle interventions, aminosalicylic acid preparations, corticosteroid drugs, biologics, fecal microbiota transplantation, and other drugs for symptomatic treatment. This review provides a detailed theoretical basis for the pathology and treatment of UC. Future research could focus on optimizing the treatment plan and achieving more precise and personalized treatment with multiple targets in multiple aspects.<\/jats:p>","DOI":"10.1038\/s41392-025-02345-1","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:03:09Z","timestamp":1770768189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Ulcerative colitis: signaling pathways, therapeutic targets and interventional strategies"],"prefix":"10.1038","volume":"11","author":[{"given":"Jinhao","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohai","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiusheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4151-9151","authenticated-orcid":false,"given":"Defang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"2345_CR1","doi-asserted-by":"crossref","unstructured":"Takabayashi, K. et al. Characteristics of flat-type ulcerative colitis-associated neoplasia on chromoendoscopic imaging with indigo carmine dye spraying. Dig Endosc. 36, 446-454 (2023).","DOI":"10.1111\/den.14628"},{"key":"2345_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00535-022-01927-y","volume":"58","author":"T Noguchi","year":"2023","unstructured":"Noguchi, T. et al. Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn\u2019s disease. J. Gastroenterol. 58, 14\u201324 (2023).","journal-title":"J. Gastroenterol."},{"key":"2345_CR3","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/ibd\/izae190","volume":"31","author":"P Chan","year":"2025","unstructured":"Chan, P. et al. Systematic review: practices and programs in inflammatory bowel disease transition care. Inflamm. Bowel Dis. 31, 1404\u20131418 (2025).","journal-title":"Inflamm. Bowel Dis."},{"key":"2345_CR4","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","volume":"380","author":"I Ord\u00e1s","year":"2012","unstructured":"Ord\u00e1s, I. et al. Ulcerative colitis. Lancet 380, 1606\u20131619 (2012).","journal-title":"Lancet"},{"key":"2345_CR5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.gtc.2020.07.005","volume":"49","author":"L Du","year":"2020","unstructured":"Du, L. & Ha, C. Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol. Clin. North Am. 49, 643\u2013654 (2020).","journal-title":"Gastroenterol. Clin. North Am."},{"key":"2345_CR6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/gutjnl-2012-302311","volume":"62","author":"ML H\u00f8ivik","year":"2013","unstructured":"H\u00f8ivik, M. L. et al. Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study. Gut 62, 368\u2013375 (2013).","journal-title":"Gut"},{"key":"2345_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.7861\/clinmed.2021-0080","volume":"21","author":"JP Segal","year":"2021","unstructured":"Segal, J. P., LeBlanc, J. F. & Hart, A. L. Ulcerative colitis: an update. Clin. Med.21, 135\u2013139 (2021).","journal-title":"Clin. Med."},{"key":"2345_CR8","doi-asserted-by":"crossref","unstructured":"Tarris, G. et al. Enteric viruses and inflammatory bowel disease. Viruses. 13, 104 (2021).","DOI":"10.3390\/v13010104"},{"key":"2345_CR9","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1038\/d41586-018-07276-2","volume":"563","author":"M Eisenstein","year":"2018","unstructured":"Eisenstein, M. Ulcerative colitis: towards remission. Nature 563, S33 (2018).","journal-title":"Nature"},{"key":"2345_CR10","first-page":"xiii","volume":"49","author":"AL Buchman","year":"2020","unstructured":"Buchman, A. L. Ulcerative colitis: where we are and where we are not in 2020. Gastroenterol. Clin. North Am. 49, xiii\u2013xiv (2020).","journal-title":"Gastroenterol. Clin. North Am."},{"key":"2345_CR11","doi-asserted-by":"crossref","unstructured":"He, Z. et al. Adiposity as a risk factor for inflammatory bowel disease and the mediating effect of metabolic and inflammatory status: a population-based cohort study. United Eur. Gastroenterol. J. 11, 973\u2013984 (2023).","DOI":"10.1002\/ueg2.12468"},{"key":"2345_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12876-021-01724-6","volume":"21","author":"S Furukawa","year":"2021","unstructured":"Furukawa, S. et al. The inverse association between unhealthy eating habit and mucosal healing among patients with ulcerative colitis. BMC Gastroenterol. 21, 152 (2021).","journal-title":"BMC Gastroenterol."},{"key":"2345_CR13","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1097\/MEG.0000000000002670","volume":"35","author":"C Liu","year":"2023","unstructured":"Liu, C. et al. The correlation between serum 25-hydroxyvitamin D level and ulcerative colitis: a systematic review and meta-analysis. Eur. J. Gastroenterol. Hepatol. 35, 1375\u20131381 (2023).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"2345_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1097\/CM9.0000000000003542","volume":"138","author":"J Wan","year":"2025","unstructured":"Wan, J. et al. Epidemiology, pathogenesis, diagnosis, and treatment of inflammatory bowel disease: Insights from the past two years. Chin. Med. J.138, 763\u2013776 (2025).","journal-title":"Chin. Med. J."},{"key":"2345_CR15","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s12325-023-02473-6","volume":"40","author":"M Barreiro-de Acosta","year":"2023","unstructured":"Barreiro-de Acosta, M. et al. Epidemiological, clinical, patient-reported and economic burden of inflammatory bowel disease (Ulcerative colitis and Crohn\u2019s disease) in Spain: a systematic review. Adv. Ther. 40, 1975\u20132014 (2023).","journal-title":"Adv. Ther."},{"key":"2345_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.592084","volume":"11","author":"B Tang","year":"2020","unstructured":"Tang, B. et al. Therapeutic potential of triptolide as an anti-inflammatory agent in dextran sulfate sodium-induced murine experimental colitis. Front. Immunol. 11, 592084 (2020).","journal-title":"Front. Immunol."},{"key":"2345_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi, T. et al. Ulcerative colitis. Nat. Rev. Dis. Prim. 6, 74 (2020).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2345_CR18","doi-asserted-by":"crossref","unstructured":"Vieujean, S. et al. Understanding the therapeutic toolkit for inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 22, 371\u2013394 (2025).","DOI":"10.1038\/s41575-024-01035-7"},{"key":"2345_CR19","doi-asserted-by":"publisher","first-page":"1225616","DOI":"10.3389\/fmed.2023.1225616","volume":"10","author":"N Abu-Freha","year":"2023","unstructured":"Abu-Freha, N. et al. Colorectal cancer among inflammatory bowel disease patients: risk factors and prevalence compared to the general population. Front. Med.10, 1225616 (2023).","journal-title":"Front. Med."},{"key":"2345_CR20","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3748\/wjg.v27.i22.2963","volume":"27","author":"Y Sun","year":"2021","unstructured":"Sun, Y., Zhang, Z., Zheng, C. Q. & Sang, L. X. Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: A review. World J. Gastroenterol. 27, 2963\u20132978 (2021).","journal-title":"World J. Gastroenterol."},{"key":"2345_CR21","doi-asserted-by":"publisher","first-page":"316","DOI":"10.7326\/M15-1190","volume":"163","author":"DB Sachar","year":"2015","unstructured":"Sachar, D. B. Ulcerative colitis: dead or alive. Ann. Intern. Med. 163, 316\u2013317 (2015).","journal-title":"Ann. Intern. Med."},{"key":"2345_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/ecco-jcc\/jjad011","volume":"17","author":"MJ Chang","year":"2023","unstructured":"Chang, M. J. et al. A compendium of mucosal molecular characteristics provides novel perspectives on the treatment of ulcerative colitis. J. Crohns Colitis 17, 909\u2013918 (2023).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156456","volume":"139","author":"C Chen","year":"2025","unstructured":"Chen, C. et al. Shengjiang Xiexin Decoction ameliorates DSS-induced ulcerative colitis via activating Wnt\/\u03b2-Catenin signaling to enhance epithelium renovation and modulating intestinal flora. Phytomedicine 139, 156456 (2025).","journal-title":"Phytomedicine"},{"key":"2345_CR24","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/ecco-jcc\/jjy129","volume":"12","author":"JLA Vleugels","year":"2018","unstructured":"Vleugels, J. L. A. et al. Diagnostic accuracy of endoscopic trimodal imaging and chromoendoscopy for lesion characterization in ulcerative colitis. J. Crohns Colitis 12, 1438\u20131447 (2018).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR25","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3389\/fimmu.2018.02211","volume":"9","author":"HP Sham","year":"2018","unstructured":"Sham, H. P. et al. Immune stimulation using a gut microbe-based immunotherapy reduces disease pathology and improves barrier function in ulcerative colitis. Front. Immunol. 9, 2211 (2018).","journal-title":"Front. Immunol."},{"key":"2345_CR26","doi-asserted-by":"publisher","first-page":"1396221","DOI":"10.3389\/fimmu.2024.1396221","volume":"15","author":"YF Zhang","year":"2024","unstructured":"Zhang, Y. F. et al. Precision therapy for ulcerative colitis: insights from mitochondrial dysfunction interacting with the immune microenvironment. Front. Immunol. 15, 1396221 (2024).","journal-title":"Front. Immunol."},{"key":"2345_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104892","volume":"159","author":"V Annese","year":"2020","unstructured":"Annese, V. Genetics and epigenetics of IBD. Pharm. Res. 159, 104892 (2020).","journal-title":"Pharm. Res."},{"key":"2345_CR28","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s12325-022-02364-2","volume":"40","author":"M Regueiro","year":"2023","unstructured":"Regueiro, M. et al. Burden of fatigue among patients with ulcerative colitis and Crohn\u2019s disease: results from a global survey of patients and gastroenterologists. Adv. Ther. 40, 474\u2013488 (2023).","journal-title":"Adv. Ther."},{"key":"2345_CR29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.5009\/gnl220181","volume":"16","author":"JW Lee","year":"2022","unstructured":"Lee, J. W. Ulcerative Colitis and Patient\u2019s quality of life, especially in early Stage. Gut Liver 16, 317\u2013318 (2022).","journal-title":"Gut Liver"},{"key":"2345_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112637","volume":"42","author":"A B\u00e9nard","year":"2023","unstructured":"B\u00e9nard, A. et al. IL-3 orchestrates ulcerative colitis pathogenesis by controlling the development and the recruitment of splenic reservoir neutrophils. Cell Rep. 42, 112637 (2023).","journal-title":"Cell Rep."},{"key":"2345_CR31","doi-asserted-by":"crossref","unstructured":"Leoncini, G. et al. Mucin expression profiles in ulcerative colitis: new insights on the histological mucosal healing. Int. J. Mol Sci. 25, 1858 (2024).","DOI":"10.3390\/ijms25031858"},{"key":"2345_CR32","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/jgh.16434","volume":"39","author":"S Kim","year":"2024","unstructured":"Kim, S. et al. Gut microbial signatures in clinically stable ulcerative colitis according to the mucosal state and associated symptoms. J. Gastroenterol. Hepatol. 39, 319\u2013327 (2024).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2345_CR33","first-page":"5191","volume":"12","author":"M Grzymis\u0142awski","year":"2006","unstructured":"Grzymis\u0142awski, M., Derc, K., Sobieska, M. & Wiktorowicz, K. Microheterogeneity of acute phase proteins in patients with ulcerative colitis. World J. Gastroenterol. 12, 5191\u20135195 (2006).","journal-title":"World J. Gastroenterol."},{"key":"2345_CR34","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","volume":"162","author":"SC Shah","year":"2022","unstructured":"Shah, S. C. & Itzkowitz, S. H. Colorectal cancer in inflammatory bowel disease: mechanisms and management. Gastroenterology 162, 715\u2013730.e713 (2022).","journal-title":"Gastroenterology"},{"key":"2345_CR35","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","volume":"11","author":"F Magro","year":"2017","unstructured":"Magro, F. et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J. Crohns Colitis 11, 649\u2013670 (2017).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR36","first-page":"Cd011450","volume":"1","author":"N Mohammed Vashist","year":"2018","unstructured":"Mohammed Vashist, N. et al. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis. Cochrane Database Syst. Rev. 1, Cd011450 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2345_CR37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/MEG.0000000000002543","volume":"35","author":"G Novak","year":"2023","unstructured":"Novak, G. et al. Biopsies from ulcer edge yield higher histological activity scores than biopsies from non-ulcerated mucosa in active ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 35, 553\u2013558 (2023).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"2345_CR38","doi-asserted-by":"publisher","first-page":"101084","DOI":"10.1016\/j.ctcp.2019.101084","volume":"38","author":"D \u00c7elebi","year":"2020","unstructured":"\u00c7elebi, D., Y\u0131lmaz, E., \u015eahin, S. T. & Baydur, H. The effect of music therapy during colonoscopy on pain, anxiety and patient comfort: a randomized controlled trial. Complement Ther. Clin. Pract. 38, 101084 (2020).","journal-title":"Complement Ther. Clin. Pract."},{"key":"2345_CR39","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1053\/j.gastro.2023.02.031","volume":"164","author":"M Iacucci","year":"2023","unstructured":"Iacucci, M. et al. Artificial intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis. Gastroenterology 164, 1180\u20131188.e1182 (2023).","journal-title":"Gastroenterology"},{"key":"2345_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100124","volume":"36","author":"F Najdawi","year":"2023","unstructured":"Najdawi, F. et al. Artificial intelligence enables quantitative assessment of ulcerative colitis histology. Mod. Pathol. 36, 100124 (2023).","journal-title":"Mod. Pathol."},{"key":"2345_CR41","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1093\/ecco-jcc\/jjad035","volume":"17","author":"K Jimbo","year":"2023","unstructured":"Jimbo, K. et al. Accuracy of transperineal ultrasonography for assessing rectal lesions in paediatric ulcerative colitis: a prospective study. J. Crohns Colitis 17, 1122\u20131127 (2023).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR42","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/ecco-jcc\/jjac178","volume":"17","author":"H El-Zimaity","year":"2023","unstructured":"El-Zimaity, H. et al. Beyond Neutrophils for Predicting Relapse and Remission in Ulcerative Colitis. J. Crohns Colitis 17, 767\u2013776 (2023).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR43","doi-asserted-by":"publisher","first-page":"2357738","DOI":"10.1080\/07853890.2024.2357738","volume":"56","author":"R Gonz\u00e1lez-Moret","year":"2024","unstructured":"Gonz\u00e1lez-Moret, R. et al. Inflammatory biomarkers and psychological variables to assess quality of life in patients with inflammatory bowel disease: a cross-sectional study. Ann. Med. 56, 2357738 (2024).","journal-title":"Ann. Med."},{"key":"2345_CR44","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.dld.2023.05.004","volume":"55","author":"P Rivi\u00e8re","year":"2023","unstructured":"Rivi\u00e8re, P. et al. Deep ulcers are associated with increased C-reactive protein in active ulcerative colitis. Dig. Liver Dis. 55, 1194\u20131200 (2023).","journal-title":"Dig. Liver Dis."},{"key":"2345_CR45","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1053\/j.gastro.2022.12.007","volume":"164","author":"S Singh","year":"2023","unstructured":"Singh, S. et al. AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis. Gastroenterology 164, 344\u2013372 (2023).","journal-title":"Gastroenterology"},{"key":"2345_CR46","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/ibd\/izac217","volume":"29","author":"T Breugelmans","year":"2023","unstructured":"Breugelmans, T. et al. Aberrant Mucin expression profiles associate with pediatric inflammatory bowel disease presentation and activity. Inflamm. Bowel Dis. 29, 589\u2013601 (2023).","journal-title":"Inflamm. Bowel Dis."},{"key":"2345_CR47","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12944-020-01404-6","volume":"19","author":"A Gholamrezayi","year":"2020","unstructured":"Gholamrezayi, A. et al. Characterization of the serum levels of Meteorin-like in patients with inflammatory bowel disease and its association with inflammatory cytokines. Lipids Health Dis. 19, 230 (2020).","journal-title":"Lipids Health Dis."},{"key":"2345_CR48","doi-asserted-by":"publisher","first-page":"1198988","DOI":"10.3389\/fmed.2023.1198988","volume":"10","author":"H Chen","year":"2023","unstructured":"Chen, H. et al. Association of serum lipids with inflammatory bowel disease: a systematic review and meta-analysis. Front. Med. 10, 1198988 (2023).","journal-title":"Front. Med."},{"key":"2345_CR49","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3390\/metabo13091006","volume":"13","author":"M Wo\u017aniak","year":"2023","unstructured":"Wo\u017aniak, M. et al. Clinical significance of erythroferrone and bone morphogenetic protein-6 in patients with anemia in the course of inflammatory bowel disease. Metabolites 13, 1006 (2023).","journal-title":"Metabolites"},{"key":"2345_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00014-21","volume":"89","author":"J Zou","year":"2021","unstructured":"Zou, J. et al. Cross talk between gut microbiota and intestinal mucosal immunity in the development of ulcerative colitis. Infect. Immun. 89, e0001421 (2021).","journal-title":"Infect. Immun."},{"key":"2345_CR51","doi-asserted-by":"crossref","unstructured":"Jangi, S. et al. Dynamics of the gut mycobiome in patients with ulcerative colitis. Clin Gastroenterol. Hepatol. 22, 821\u2013830 (2023).","DOI":"10.1016\/j.cgh.2023.09.023"},{"key":"2345_CR52","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1053\/j.gastro.2022.12.042","volume":"164","author":"AE Livanos","year":"2023","unstructured":"Livanos, A. E. et al. Anti-integrin \u03b1v\u03b26 autoantibodies are a novel biomarker that antedate ulcerative colitis. Gastroenterology 164, 619\u2013629 (2023).","journal-title":"Gastroenterology"},{"key":"2345_CR53","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/ecco-jcc\/jjac191","volume":"17","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. Bidirectional mendelian randomisation analysis provides evidence for the causal involvement of dysregulation of CXCL9, CCL11 and CASP8 in the pathogenesis of ulcerative colitis. J. Crohns Colitis 17, 777\u2013785 (2023).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR54","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3390\/cells12151953","volume":"12","author":"F Di Vincenzo","year":"2023","unstructured":"Di Vincenzo, F. et al. Circular and circulating DNA in inflammatory bowel disease: from pathogenesis to potential molecular therapies. Cells 12, 1953 (2023).","journal-title":"Cells"},{"key":"2345_CR55","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00726-023-03233-0","volume":"55","author":"G Zhou","year":"2023","unstructured":"Zhou, G. et al. Amino acids-targeted metabolomics reveals novel diagnostic biomarkers for ulcerative colitis and Crohn\u2019s disease. Amino Acids 55, 349\u2013358 (2023).","journal-title":"Amino Acids"},{"key":"2345_CR56","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12866-021-02342-8","volume":"21","author":"HM Xu","year":"2021","unstructured":"Xu, H. M. et al. Selection strategy of dextran sulfate sodium-induced acute or chronic colitis mouse models based on gut microbial profile. BMC Microbiol. 21, 279 (2021).","journal-title":"BMC Microbiol."},{"key":"2345_CR57","doi-asserted-by":"crossref","unstructured":"Markov, A. V., Savin, I. A., Zenkova, M. A. & Sen\u2019kova, A. V. Identification of novel core genes involved in malignant transformation of inflamed colon tissue using a computational biology approach and verification in murine models. Int. J. Mol. Sci. 24, 4311 (2023).","DOI":"10.3390\/ijms24054311"},{"key":"2345_CR58","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10142-023-01099-9","volume":"23","author":"W Meng","year":"2023","unstructured":"Meng, W. et al. Anti-apoptotic genes and non-coding RNAs are potential outcome predictors for ulcerative colitis. Funct. Integr. Genom.23, 165 (2023).","journal-title":"Funct. Integr. Genom."},{"key":"2345_CR59","doi-asserted-by":"publisher","first-page":"e00489","DOI":"10.14309\/ctg.0000000000000489","volume":"13","author":"I Quintanilla","year":"2022","unstructured":"Quintanilla, I. et al. Differentially deregulated MicroRNAs as novel biomarkers for neoplastic progression in ulcerative colitis. Clin. Transl. Gastroenterol. 13, e00489 (2022).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"2345_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202200884","volume":"67","author":"L Ma","year":"2023","unstructured":"Ma, L. et al. Anti-inflammatory effect of clostridium butyricum-derived extracellular vesicles in ulcerative colitis: impact on host micrornas expressions and gut microbiome profiles. Mol. Nutr. Food Res. 67, e2200884 (2023).","journal-title":"Mol. Nutr. Food Res."},{"key":"2345_CR61","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ncrna.2022.02.001","volume":"7","author":"MK Ray","year":"2022","unstructured":"Ray, M. K., Fenton, C. G. & Paulssen, R. H. Novel long non-coding RNAs of relevance for ulcerative colitis pathogenesis. Noncoding RNA Res. 7, 40\u201347 (2022).","journal-title":"Noncoding RNA Res."},{"key":"2345_CR62","doi-asserted-by":"crossref","unstructured":"G\u0142\u0105bska, D., Guzek, D. & Lech, G. Analysis of the nutritional value of diets and food choices in polish female ulcerative colitis individuals compared with a pair-matched control sample. Nutrients. 15, 857 (2023).","DOI":"10.3390\/nu15040857"},{"key":"2345_CR63","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/1751-2980.13165","volume":"24","author":"B Sim","year":"2023","unstructured":"Sim, B. et al. Approximately 1 in 10 ambulatory inflammatory bowel disease patients are at risk of malnutrition: a prospective Singapore cohort. J. Dig. Dis. 24, 10\u201318 (2023).","journal-title":"J. Dig. Dis."},{"key":"2345_CR64","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jfma.2022.11.004","volume":"122","author":"PY Hsiao","year":"2023","unstructured":"Hsiao, P. Y. et al. Anemia in inflammatory bowel disease course is associated with patients\u2019 worse outcome. J. Formos. Med. Assoc. 122, 549\u2013556 (2023).","journal-title":"J. Formos. Med. Assoc."},{"key":"2345_CR65","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.dld.2024.12.011","volume":"57","author":"E Louis","year":"2025","unstructured":"Louis, E. et al. Change in fatigue in patients with ulcerative colitis or Crohn\u2019s disease initiating biologic therapy. Dig. Liver Dis. 57, 707\u2013715 (2025).","journal-title":"Dig. Liver Dis."},{"key":"2345_CR66","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12876-023-02693-8","volume":"23","author":"X Gao","year":"2023","unstructured":"Gao, X., Duan, S., Cao, Y. & Zhang, Y. Change of monocytes\/macrophages in ulcerative colitis patients with symptoms of anxiety and depression. BMC Gastroenterol. 23, 67 (2023).","journal-title":"BMC Gastroenterol."},{"key":"2345_CR67","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.canlet.2013.07.032","volume":"345","author":"G Rogler","year":"2014","unstructured":"Rogler, G. Chronic ulcerative colitis and colorectal cancer. Cancer Lett. 345, 235\u2013241 (2014).","journal-title":"Cancer Lett."},{"key":"2345_CR68","doi-asserted-by":"publisher","first-page":"16389","DOI":"10.3748\/wjg.v20.i44.16389","volume":"20","author":"M Yashiro","year":"2014","unstructured":"Yashiro, M. Ulcerative colitis-associated colorectal cancer. World J. Gastroenterol. 20, 16389\u201316397 (2014).","journal-title":"World J. Gastroenterol."},{"key":"2345_CR69","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold, M. et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut 66, 683\u2013691 (2017).","journal-title":"Gut"},{"key":"2345_CR70","doi-asserted-by":"publisher","first-page":"1523584","DOI":"10.3389\/fimmu.2025.1523584","volume":"16","author":"X Cui","year":"2025","unstructured":"Cui, X. et al. Gut microbiota - bidirectional modulator: role in inflammatory bowel disease and colorectal cancer. Front. Immunol. 16, 1523584 (2025).","journal-title":"Front. Immunol."},{"key":"2345_CR71","doi-asserted-by":"publisher","first-page":"1155123","DOI":"10.3389\/fonc.2023.1155123","volume":"13","author":"Y min","year":"2023","unstructured":"min, Y. et al. Association between inflammatory bowel disease and pancreatic cancer: results from the two-sample Mendelian randomization study. Front. Oncol. 13, 1155123 (2023).","journal-title":"Front. Oncol."},{"key":"2345_CR72","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00384-023-04465-y","volume":"38","author":"BG Zhou","year":"2023","unstructured":"Zhou, B. G. et al. Association between inflammatory bowel disease and risk of incident prostate cancer: a systematic review and meta-analysis of cohort studies. Int. J. Colorectal Dis. 38, 168 (2023).","journal-title":"Int. J. Colorectal Dis."},{"key":"2345_CR73","doi-asserted-by":"publisher","first-page":"13599","DOI":"10.1002\/cam4.6057","volume":"12","author":"J Huang","year":"2023","unstructured":"Huang, J. et al. Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: a two-sample Mendelian randomization analysis of European and East Asian populations. Cancer Med 12, 13599\u201313609 (2023).","journal-title":"Cancer Med"},{"key":"2345_CR74","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/ecco-jcc\/jjad045","volume":"17","author":"A Albuquerque","year":"2023","unstructured":"Albuquerque, A., Cappello, C., Stirrup, O. & Selinger, C. P. Anal high-risk human papillomavirus infection, squamous intraepithelial lesions, and anal cancer in patients with inflammatory bowel disease: a systematic review and meta-analysis. J. Crohns Colitis 17, 1228\u20131234 (2023).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR75","doi-asserted-by":"crossref","unstructured":"Yang, Y. et al. Absolute and relative risks of kidney and urological complications in patients with inflammatory bowel disease. Am. J. Gastroenterol. 119, 138\u2013146 (2023).","DOI":"10.14309\/ajg.0000000000002473"},{"key":"2345_CR76","doi-asserted-by":"crossref","unstructured":"Faye, A. S. et al. Atherosclerosis as a risk factor of inflammatory bowel disease: a population-based case-control study. Am. J. Gastroenterol. 119, 313\u2013322 (2023).","DOI":"10.14309\/ajg.0000000000002502"},{"key":"2345_CR77","doi-asserted-by":"publisher","first-page":"1267834","DOI":"10.3389\/fimmu.2023.1267834","volume":"14","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. Causal atlas between inflammatory bowel disease and mental disorders: a bi-directional 2-sample Mendelian randomization study. Front. Immunol. 14, 1267834 (2023).","journal-title":"Front. Immunol."},{"key":"2345_CR78","doi-asserted-by":"publisher","first-page":"1175873","DOI":"10.3389\/fimmu.2023.1175873","volume":"14","author":"S He","year":"2023","unstructured":"He, S., Peng, Y., Chen, X. & Ou, Y. Causality between inflammatory bowel disease and the cerebral cortex: insights from Mendelian randomization and integrated bioinformatics analysis. Front. Immunol. 14, 1175873 (2023).","journal-title":"Front. Immunol."},{"key":"2345_CR79","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/MEG.0000000000002445","volume":"35","author":"E Theodoraki","year":"2023","unstructured":"Theodoraki, E. et al. Active smoking is associated with the development of adverse events of biological therapy in patients with inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 35, 15\u201320 (2023).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"2345_CR80","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fimmu.2018.00074","volume":"9","author":"L Berkowitz","year":"2018","unstructured":"Berkowitz, L. et al. Impact of cigarette smoking on the gastrointestinal tract inflammation: opposing effects in Crohn\u2019s disease and ulcerative colitis. Front. Immunol. 9, 74 (2018).","journal-title":"Front. Immunol."},{"key":"2345_CR81","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108863","volume":"40","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky, D. J. et al. Autophagy in major human diseases. Embo J. 40, e108863 (2021).","journal-title":"Embo J."},{"key":"2345_CR82","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.7150\/ijbs.67356","volume":"18","author":"C Chen","year":"2022","unstructured":"Chen, C. et al. Atrial Natriuretic peptide attenuates colitis via inhibition of the cGAS-STING pathway in colonic epithelial cells. Int. J. Biol. Sci. 18, 1737\u20131754 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"2345_CR83","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1080\/15548627.2020.1847460","volume":"17","author":"S Kim","year":"2021","unstructured":"Kim, S. et al. ESRRA (estrogen related receptor alpha) is a critical regulator of intestinal homeostasis through activation of autophagic flux via gut microbiota. Autophagy 17, 2856\u20132875 (2021).","journal-title":"Autophagy"},{"key":"2345_CR84","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.molimm.2023.06.002","volume":"160","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Autotaxin promotes the degradation of the mucus layer by inhibiting autophagy in mouse colitis. Mol. Immunol. 160, 44\u201354 (2023).","journal-title":"Mol. Immunol."},{"key":"2345_CR85","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/ibd\/izab188","volume":"28","author":"Y Xu","year":"2022","unstructured":"Xu, Y. et al. Circular RNA HECTD1 mitigates ulcerative colitis by promoting enterocyte autophagy via miR-182-5p\/HuR Axis. Inflamm. Bowel Dis. 28, 273\u2013288 (2022).","journal-title":"Inflamm. Bowel Dis."},{"key":"2345_CR86","doi-asserted-by":"publisher","first-page":"55","DOI":"10.15698\/cst2018.03.127","volume":"2","author":"M Nagata","year":"2018","unstructured":"Nagata, M. et al. Dram1 regulates DNA damage-induced alternative autophagy. Cell Stress 2, 55\u201365 (2018).","journal-title":"Cell Stress"},{"key":"2345_CR87","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1007\/s10620-020-06697-2","volume":"66","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. DNA damage-regulated autophagy Modulator 1 (DRAM1) mediates autophagy and apoptosis of intestinal epithelial cells in inflammatory bowel disease. Dig. Dis. Sci. 66, 3375\u20133390 (2021).","journal-title":"Dig. Dis. Sci."},{"key":"2345_CR88","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1089\/dna.2020.6380","volume":"40","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Exogenous H(2)S protects colon cells in ulcerative colitis by inhibiting NLRP3 and activating autophagy. DNA Cell Biol. 40, 748\u2013756 (2021).","journal-title":"DNA Cell Biol."},{"key":"2345_CR89","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1039\/D1FO03360C","volume":"13","author":"P Li","year":"2022","unstructured":"Li, P. et al. Live Lactobacillus acidophilus alleviates ulcerative colitis via the SCFAs\/mitophagy\/NLRP3 inflammasome axis. Food Funct. 13, 2985\u20132997 (2022).","journal-title":"Food Funct."},{"key":"2345_CR90","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14825","volume":"9","author":"F Abbasi Teshnizi","year":"2021","unstructured":"Abbasi Teshnizi, F. et al. A study on the potential role of autophagy-related protein 10 as a biomarker for ulcerative colitis. Physiol. Rep. 9, e14825 (2021).","journal-title":"Physiol. Rep."},{"key":"2345_CR91","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00018-015-2052-6","volume":"73","author":"DS Schwarz","year":"2016","unstructured":"Schwarz, D. S. & Blower, M. D. The endoplasmic reticulum: structure, function and response to cellular signaling. Cell Mol. Life Sci. 73, 79\u201394 (2016).","journal-title":"Cell Mol. Life Sci."},{"key":"2345_CR92","doi-asserted-by":"publisher","first-page":"1270085","DOI":"10.3389\/fgene.2023.1270085","volume":"14","author":"M Zou","year":"2023","unstructured":"Zou, M. et al. Endoplasmic reticulum stress related genome-wide Mendelian randomization identifies therapeutic genes for ulcerative colitis and Crohn\u2019s disease. Front. Genet. 14, 1270085 (2023).","journal-title":"Front. Genet."},{"key":"2345_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106498","volume":"26","author":"B Feng","year":"2023","unstructured":"Feng, B. et al. ER stress modulates the immune regulatory ability in gut M2 cells of patients with ulcerative colitis. iScience 26, 106498 (2023).","journal-title":"iScience"},{"key":"2345_CR94","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/febs.14740","volume":"286","author":"SJ Marciniak","year":"2019","unstructured":"Marciniak, S. J. Endoplasmic reticulum stress: a key player in human disease. FEBS J. 286, 228\u2013231 (2019).","journal-title":"FEBS J."},{"key":"2345_CR95","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6049500","volume":"2022","author":"BL Rodrigues","year":"2022","unstructured":"Rodrigues, B. L. et al. Endoplasmic reticulum stress in colonic mucosa of ulcerative colitis patients is mediated by PERK and IRE1 pathway activation. Mediators Inflamm. 2022, 6049500 (2022).","journal-title":"Mediators Inflamm."},{"key":"2345_CR96","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1007\/s10620-020-06622-7","volume":"66","author":"B Zhang","year":"2021","unstructured":"Zhang, B. et al. Inositol-Requiring Kinase 1 regulates apoptosis via inducing endoplasmic reticulum stress in colitis epithelial cells. Dig. Dis. Sci. 66, 3015\u20133025 (2021).","journal-title":"Dig. Dis. Sci."},{"key":"2345_CR97","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/ecco-jcc\/jjab035","volume":"15","author":"N Sol\u00e0 Tapias","year":"2021","unstructured":"Sol\u00e0 Tapias, N. et al. Colitis linked to endoplasmic reticulum stress induces trypsin activity affecting epithelial functions. J. Crohns Colitis 15, 1528\u20131541 (2021).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR98","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jcmgh.2020.11.006","volume":"11","author":"JP Kennelly","year":"2021","unstructured":"Kennelly, J. P. et al. Intestinal phospholipid disequilibrium initiates an ER stress response that drives goblet cell necroptosis and spontaneous colitis in mice. Cell Mol. Gastroenterol. Hepatol. 11, 999\u20131021 (2021).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"2345_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1900996","volume":"13","author":"R Wang","year":"2021","unstructured":"Wang, R. et al. Gut microbiota shape the inflammatory response in mice with an epithelial defect. Gut Microbes 13, 1\u201318 (2021).","journal-title":"Gut Microbes"},{"key":"2345_CR100","doi-asserted-by":"crossref","unstructured":"Moniruzzaman, M. et al. IL-20 Activates ERK1\/2 and suppresses splicing of X-Box Protein-1 in intestinal epithelial cells but does not improve pathology in acute or chronic models of colitis. Int. J. Mol. Sci. 24, 174 (2022).","DOI":"10.3390\/ijms24010174"},{"key":"2345_CR101","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4149\/gpb_2022012","volume":"41","author":"L Ma","year":"2022","unstructured":"Ma, L. et al. Omentin-1 attenuates inflammation and barrier damage in DSS-induced ulcerative colitis in mice by inhibiting endoplasmic reticulum stress. Gen. Physiol. Biophys. 41, 221\u2013230 (2022).","journal-title":"Gen. Physiol. Biophys."},{"key":"2345_CR102","doi-asserted-by":"crossref","unstructured":"Annesley, S. J. & Fisher, P. R. Mitochondria in health and disease. Cells. 8, 680 (2019).","DOI":"10.3390\/cells8070680"},{"key":"2345_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1231700","volume":"14","author":"EA Novak","year":"2023","unstructured":"Novak, E. A. et al. Epithelial NAD(+) depletion drives mitochondrial dysfunction and contributes to intestinal inflammation. Front. Immunol. 14, 1231700 (2023).","journal-title":"Front. Immunol."},{"key":"2345_CR104","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goac028","volume":"10","author":"YD Chen","year":"2022","unstructured":"Chen, Y. D. et al. The association between disruption of the circadian rhythm and aggravation of colitis in mice. Gastroenterol. Rep.10, goac028 (2022).","journal-title":"Gastroenterol. Rep."},{"key":"2345_CR105","doi-asserted-by":"crossref","unstructured":"Fu, S. C. et al. Excessive mitochondrial fission suppresses mucosal repair by impairing butyrate metabolism in colonocytes. Inflamm. Bowel Dis. 30, 114\u2013124 (2023).","DOI":"10.1093\/ibd\/izad132"},{"key":"2345_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.893426","volume":"13","author":"H Liang","year":"2022","unstructured":"Liang, H. et al. Heat shock transcription factor 2 promotes mitophagy of intestinal epithelial cells through PARL\/PINK1\/Parkin pathway in ulcerative colitis. Front. Pharm. 13, 893426 (2022).","journal-title":"Front. Pharm."},{"key":"2345_CR107","doi-asserted-by":"publisher","first-page":"108810","DOI":"10.1016\/j.intimp.2022.108810","volume":"108","author":"A Yaghoubi","year":"2022","unstructured":"Yaghoubi, A., Amel Jamehdar, S., Reza Akbari Eidgahi, M. & Ghazvini, K. Evaluation of the therapeutic effect of melittin peptide on the ulcerative colitis mouse model. Int. Immunopharmacol. 108, 108810 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"2345_CR108","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.advms.2021.10.002","volume":"67","author":"L Song","year":"2022","unstructured":"Song, L. et al. Hydrogen-rich water partially alleviate inflammation, oxidative stress and intestinal flora dysbiosis in DSS-induced chronic ulcerative colitis mice. Adv. Med. Sci. 67, 29\u201338 (2022).","journal-title":"Adv. Med. Sci."},{"key":"2345_CR109","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1055\/a-1389-5499","volume":"71","author":"T Gandhi","year":"2021","unstructured":"Gandhi, T. et al. Lansoprazole a Proton Pump Inhibitor Prevents IBD by reduction of oxidative stress and NO levels in the rat. Drug Res.71, 379\u2013387 (2021).","journal-title":"Drug Res."},{"key":"2345_CR110","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","volume":"44","author":"TA Wynn","year":"2016","unstructured":"Wynn, T. A. & Vannella, K. M. Macrophages in tissue repair, regeneration, and fibrosis. Immunity 44, 450\u2013462 (2016).","journal-title":"Immunity"},{"key":"2345_CR111","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1146\/annurev-immunol-032414-112220","volume":"33","author":"C Varol","year":"2015","unstructured":"Varol, C., Mildner, A. & Jung, S. Macrophages: development and tissue specialization. Annu. Rev. Immunol. 33, 643\u2013675 (2015).","journal-title":"Annu. Rev. Immunol."},{"key":"2345_CR112","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jpha.2023.07.001","volume":"13","author":"S Ma","year":"2023","unstructured":"Ma, S. et al. 1,8-cineole ameliorates colon injury by downregulating macrophage M1 polarization via inhibiting the HSP90-NLRP3-SGT1 complex. J. Pharm. Anal. 13, 984\u2013998 (2023).","journal-title":"J. Pharm. Anal."},{"key":"2345_CR113","doi-asserted-by":"crossref","unstructured":"Khan, S. et al. CLUH functions as a negative regulator of inflammation in human macrophages and determines ulcerative colitis pathogenesis. JCI Insight. 8, e161096 (2023).","DOI":"10.1172\/jci.insight.161096"},{"key":"2345_CR114","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s10787-023-01226-9","volume":"31","author":"M Guo","year":"2023","unstructured":"Guo, M. et al. Human TFF2-Fc fusion protein alleviates DSS-induced ulcerative colitis in C57BL\/6 mice by promoting intestinal epithelial cells repair and inhibiting macrophage inflammation. Inflammopharmacology 31, 1387\u20131404 (2023).","journal-title":"Inflammopharmacology"},{"key":"2345_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.700009","volume":"12","author":"P Li","year":"2021","unstructured":"Li, P. et al. Comparative proteomic analysis of polarized human THP-1 and Mouse RAW264.7 Macrophages. Front. Immunol. 12, 700009 (2021).","journal-title":"Front. Immunol."},{"key":"2345_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110731","volume":"123","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. FTY720 attenuates acute colitis via colonic T cells reduction and inhibition of M1 macrophages polarization independent of CCR2-mediated monocytes input. Int. Immunopharmacol. 123, 110731 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"2345_CR117","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01208-23","volume":"14","author":"AM Vlk","year":"2023","unstructured":"Vlk, A. M. et al. M2a macrophages facilitate resolution of chemically-induced colitis in TLR4-SNP mice. mBio 14, e0120823 (2023).","journal-title":"mBio"},{"key":"2345_CR118","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12934-022-01812-6","volume":"21","author":"L Liang","year":"2022","unstructured":"Liang, L. et al. Commensal bacteria-derived extracellular vesicles suppress ulcerative colitis through regulating the macrophages polarization and remodeling the gut microbiota. Micro Cell Fact. 21, 88 (2022).","journal-title":"Micro Cell Fact."},{"key":"2345_CR119","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1111\/jcmm.16348","volume":"25","author":"J Lu","year":"2021","unstructured":"Lu, J. et al. M1 Macrophage exosomes MiR-21a-5p aggravates inflammatory bowel disease through decreasing E-cadherin and subsequent ILC2 activation. J. Cell Mol. Med. 25, 3041\u20133050 (2021).","journal-title":"J. Cell Mol. Med."},{"key":"2345_CR120","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/ecco-jcc\/jjaa214","volume":"15","author":"F Deng","year":"2021","unstructured":"Deng, F. et al. M2 macrophage-derived exosomal miR-590-3p attenuates DSS-induced mucosal damage and promotes epithelial repair via the LATS1\/YAP\/ \u03b2-catenin signalling axis. J. Crohns Colitis 15, 665\u2013677 (2021).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR121","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000525753","volume":"63","author":"L Hu","year":"2022","unstructured":"Hu, L. et al. Interferon Regulatory Factor 4 (IRF4) promotes lipopolysaccharide-induced colonic mucosal epithelial cell proliferation by regulating macrophage polarization. Eur. Surg. Res. 63, 257\u2013268 (2022).","journal-title":"Eur. Surg. Res."},{"key":"2345_CR122","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1039\/D1BM01797G","volume":"10","author":"G Han","year":"2022","unstructured":"Han, G. et al. Bovine colostrum derived-exosomes prevent dextran sulfate sodium-induced intestinal colitis via suppression of inflammation and oxidative stress. Biomater. Sci. 10, 2076\u20132087 (2022).","journal-title":"Biomater. Sci."},{"key":"2345_CR123","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/21655979.2020.1859259","volume":"12","author":"Y Cao","year":"2021","unstructured":"Cao, Y. et al. Fenretinide regulates macrophage polarization to protect against experimental colitis induced by dextran sulfate sodium. Bioengineered 12, 151\u2013161 (2021).","journal-title":"Bioengineered"},{"key":"2345_CR124","doi-asserted-by":"crossref","unstructured":"Matsunaga, Y. et al. Pathological role of Pin1 in the development of DSS-Induced Colitis. Cells. 10, 1230 (2021).","DOI":"10.3390\/cells10051230"},{"key":"2345_CR125","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1042\/CS20210778","volume":"136","author":"L Liang","year":"2022","unstructured":"Liang, L. et al. Gut microbiota-derived butyrate regulates gut mucus barrier repair by activating the macrophage\/WNT\/ERK signaling pathway. Clin. Sci.136, 291\u2013307 (2022).","journal-title":"Clin. Sci."},{"key":"2345_CR126","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s10753-020-01403-w","volume":"44","author":"TCM Lopes","year":"2021","unstructured":"Lopes, T. C. M. et al. High-density-immune-complex regulatory macrophages promote recovery of experimental colitis in mice. Inflammation 44, 1069\u20131082 (2021).","journal-title":"Inflammation"},{"key":"2345_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.777665","volume":"12","author":"S Sun","year":"2021","unstructured":"Sun, S. et al. Lactic acid-producing probiotic saccharomyces cerevisiae attenuates ulcerative colitis via suppressing macrophage pyroptosis and modulating gut microbiota. Front. Immunol. 12, 777665 (2021).","journal-title":"Front. Immunol."},{"key":"2345_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1020670","volume":"13","author":"LK Gong","year":"2022","unstructured":"Gong, L. K. et al. Low-dose ganciclovir ameliorates dextran sulfate sodium-induced ulcerative colitis through inhibiting macrophage STING activation in mice. Front. Pharm. 13, 1020670 (2022).","journal-title":"Front. Pharm."},{"key":"2345_CR129","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1007\/s10620-021-07067-2","volume":"66","author":"J Lu","year":"2021","unstructured":"Lu, J. et al. Thalidomide attenuates colitis and is associated with the suppression of M1 macrophage polarization by targeting the transcription factor IRF5. Dig. Dis. Sci. 66, 3803\u20133812 (2021).","journal-title":"Dig. Dis. Sci."},{"key":"2345_CR130","doi-asserted-by":"crossref","unstructured":"Zhang, J. et al. GRK2 mediates macrophage polarization by regulating EP4-cAMP-pCREB signaling in ulcerative colitis and the therapeutic effect of paroxetine on mice with DSS-induced colitis. Pharmaceuticals 16, 664 (2023).","DOI":"10.3390\/ph16050664"},{"key":"2345_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01191-4","volume":"21","author":"L Yan","year":"2023","unstructured":"Yan, L., Li, J. & Zhang, C. The role of MSCs and CAR-MSCs in cellular immunotherapy. Cell Commun. Signal 21, 187 (2023).","journal-title":"Cell Commun. Signal"},{"key":"2345_CR132","doi-asserted-by":"crossref","unstructured":"Yang, W. et al. Colon-targeted EMSCs conditional medium hydrogel for treatment of ulcerative colitis in mice. Biomed. Mater. 18, (2023).","DOI":"10.1088\/1748-605X\/acfadb"},{"key":"2345_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107868","volume":"26","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q. et al. ERK1-mediated immunomodulation of mesenchymal stem cells ameliorates inflammatory disorders. iScience 26, 107868 (2023).","journal-title":"iScience"},{"key":"2345_CR134","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s10620-022-07722-2","volume":"68","author":"P Liu","year":"2023","unstructured":"Liu, P. et al. Mesenchymal stem cells promote intestinal mucosal repair by positively regulating the Nrf2\/Keap1\/ARE signaling pathway in acute experimental colitis. Dig. Dis. Sci. 68, 1835\u20131846 (2023).","journal-title":"Dig. Dis. Sci."},{"key":"2345_CR135","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1111\/jgh.15987","volume":"37","author":"H He","year":"2022","unstructured":"He, H. et al. Extracellular vesicles produced by bone marrow mesenchymal stem cells overexpressing programmed death-ligand 1 ameliorate dextran sodium sulfate-induced ulcerative colitis in rats by regulating Th17\/Treg cell balance through PTEN\/PI3K\/AKT\/mTOR axis. J. Gastroenterol. Hepatol. 37, 2243\u20132254 (2022).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2345_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109426","volume":"113","author":"F Zhu","year":"2022","unstructured":"Zhu, F. et al. Hypoxic mesenchymal stem cell-derived exosomes alleviate ulcerative colitis injury by limiting intestinal epithelial cells reactive oxygen species accumulation and DNA damage through HIF-1\u03b1. Int. Immunopharmacol. 113, 109426 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"2345_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2022.101765","volume":"76","author":"Q Ding","year":"2023","unstructured":"Ding, Q. et al. Pretreating mesenchymal stem cells with IL-6 regulates the inflammatory response of DSS-induced ulcerative colitis in rats. Transpl. Immunol. 76, 101765 (2023).","journal-title":"Transpl. Immunol."},{"key":"2345_CR138","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13287-020-02098-4","volume":"12","author":"N Li","year":"2021","unstructured":"Li, N. et al. Dental pulp stem cells overexpressing hepatocyte growth factor facilitate the repair of DSS-induced ulcerative colitis. Stem Cell Res. Ther. 12, 30 (2021).","journal-title":"Stem Cell Res. Ther."},{"key":"2345_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.859806","volume":"13","author":"Y Yuan","year":"2022","unstructured":"Yuan, Y. et al. Adipose-derived mesenchymal stem cells reprogram M1 macrophage metabolism via PHD2\/HIF-1\u03b1 pathway in colitis mice. Front. Immunol. 13, 859806 (2022).","journal-title":"Front. Immunol."},{"key":"2345_CR140","doi-asserted-by":"publisher","first-page":"e00036-17","DOI":"10.1128\/MMBR.00036-17","volume":"81","author":"C Milani","year":"2017","unstructured":"Milani, C. et al. The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota. Microbiol. Mol. Biol. Rev. 81, e00036-17 (2017).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"2345_CR141","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.clnesp.2023.08.019","volume":"57","author":"S Moradi","year":"2023","unstructured":"Moradi, S. et al. The effects of spirulina supplementation on serum iron and ferritin, anemia parameters, and fecal occult blood in adults with ulcerative colitis: a randomized, double-blinded, placebo-controlled trial. Clin. Nutr. ESPEN 57, 755\u2013763 (2023).","journal-title":"Clin. Nutr. ESPEN"},{"key":"2345_CR142","doi-asserted-by":"publisher","first-page":"jjae142","DOI":"10.1093\/ecco-jcc\/jjae142","volume":"19","author":"D Moutsoglou","year":"2025","unstructured":"Moutsoglou, D. et al. Novel microbial engraftment trajectories following microbiota transplant therapy in ulcerative colitis. J. Crohns Colitis 19, jjae142 (2025).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR143","doi-asserted-by":"crossref","unstructured":"Kim, Y. J. et al. 2\u2019-Fucosyllactose and 3-Fucosyllactose Alleviates Interleukin-6-Induced barrier dysfunction and dextran sodium sulfate-induced colitis by improving intestinal barrier function and modulating the intestinal microbiome. Nutrients. 15, 1845 (2023).","DOI":"10.3390\/nu15081845"},{"key":"2345_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1127785","volume":"14","author":"H Cheng","year":"2023","unstructured":"Cheng, H. et al. Atractylodes macrocephala Koidz. volatile oil relieves acute ulcerative colitis via regulating gut microbiota and gut microbiota metabolism. Front. Immunol. 14, 1127785 (2023).","journal-title":"Front. Immunol."},{"key":"2345_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.953962","volume":"12","author":"S Zhu","year":"2022","unstructured":"Zhu, S. et al. Composition and diverse differences of intestinal microbiota in ulcerative colitis patients. Front. Cell Infect. Microbiol. 12, 953962 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"2345_CR146","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.2147\/JIR.S358807","volume":"15","author":"W Gu","year":"2022","unstructured":"Gu, W. et al. Dynamic changes in gut microbiome of ulcerative colitis: initial study from animal model. J. Inflamm. Res. 15, 2631\u20132647 (2022).","journal-title":"J. Inflamm. Res."},{"key":"2345_CR147","doi-asserted-by":"crossref","unstructured":"Wu, A. et al. Alginate Oligosaccharides prevent dextran-sulfate-sodium-induced ulcerative colitis via enhancing intestinal barrier function and modulating gut microbiota. Foods. 12, 220 (2023).","DOI":"10.3390\/foods12010220"},{"key":"2345_CR148","doi-asserted-by":"crossref","unstructured":"Pinto, S. et al. Dynamics of gut microbiota after fecal microbiota transplantation in ulcerative colitis: success linked to control of prevotellaceae. J Crohns Colitis. 19, jjae137 (2025).","DOI":"10.1093\/ecco-jcc\/jjae137"},{"key":"2345_CR149","doi-asserted-by":"crossref","unstructured":"Stojanov, S., Berlec, A. & \u0160trukelj, B. The influence of probiotics on the firmicutes\/bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease. Microorganisms. 8, 1715 (2020).","DOI":"10.3390\/microorganisms8111715"},{"key":"2345_CR150","doi-asserted-by":"crossref","unstructured":"Rajesh, K. M. et al. Effect of chronic low-dose treatment with chitooligosaccharides on microbial dysbiosis and inflammation associated chronic ulcerative colitis in Balb\/c mice. Naunyn Schmiedebergs Arch Pharmacol. 397, 1611\u20131622 (2023).","DOI":"10.1007\/s00210-023-02710-3"},{"key":"2345_CR151","doi-asserted-by":"crossref","unstructured":"Wang, T. et al. Effect of Ornithine \u03b1-Ketoglutarate on intestinal microbiota and serum inflammatory cytokines in dextran sulfate sodium induced colitis. Nutrients. 15, 2476 (2023).","DOI":"10.3390\/nu15112476"},{"key":"2345_CR152","doi-asserted-by":"publisher","first-page":"14817","DOI":"10.1021\/acs.jafc.2c02066","volume":"70","author":"D Shen","year":"2022","unstructured":"Shen, D., Ma, S., Li, X. & Lu, Y. Effect of lactobacillus with feruloyl esterase-producing ability on dextran sodium sulfate-induced ulcerative colitis in mice. J. Agric Food Chem. 70, 14817\u201314830 (2022).","journal-title":"J. Agric Food Chem."},{"key":"2345_CR153","doi-asserted-by":"crossref","unstructured":"Guo, C. et al. Chitosan oligosaccharides alleviate colitis by regulating intestinal microbiota and PPAR\u03b3\/SIRT1-Mediated NF-\u03baB pathway. Mar. Drugs. 20, 96 (2022).","DOI":"10.3390\/md20020096"},{"key":"2345_CR154","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1039\/D0FO03479G","volume":"12","author":"B Pang","year":"2021","unstructured":"Pang, B. et al. Lactobacillus rhamnosus from human breast milk ameliorates ulcerative colitis in mice via gut microbiota modulation. Food Funct. 12, 5171\u20135186 (2021).","journal-title":"Food Funct."},{"key":"2345_CR155","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.726707","volume":"12","author":"H Ke","year":"2021","unstructured":"Ke, H. et al. Metformin exerts anti-inflammatory and mucus barrier protective effects by enriching Akkermansia muciniphila in mice with ulcerative colitis. Front. Pharm. 12, 726707 (2021).","journal-title":"Front. Pharm."},{"key":"2345_CR156","doi-asserted-by":"crossref","unstructured":"Dong, Y. et al. Docosapentaenoic Acid (DPA, 22:5n-3) alleviates ulcerative colitis via modification of gut microbiota and their metabolism. Nutrients. 14, 4204 (2022).","DOI":"10.3390\/nu14194204"},{"key":"2345_CR157","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1039\/D1FO02938J","volume":"13","author":"YY Huang","year":"2022","unstructured":"Huang, Y. Y. et al. Lactiplantibacillus plantarum DMDL 9010 alleviates dextran sodium sulfate (DSS)-induced colitis and behavioral disorders by facilitating microbiota-gut-brain axis balance. Food Funct. 13, 411\u2013424 (2022).","journal-title":"Food Funct."},{"key":"2345_CR158","doi-asserted-by":"publisher","first-page":"119430","DOI":"10.1016\/j.carbpol.2022.119430","volume":"289","author":"X Li","year":"2022","unstructured":"Li, X. et al. The potential therapeutic effects of hydroxypropyl cellulose on acute murine colitis induced by DSS. Carbohydr. Polym. 289, 119430 (2022).","journal-title":"Carbohydr. Polym."},{"key":"2345_CR159","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1002\/jsfa.12382","volume":"103","author":"J Wu","year":"2023","unstructured":"Wu, J. et al. Broccoli seed extract rich in polysaccharides and glucoraphanin ameliorates DSS-induced colitis via intestinal barrier protection and gut microbiota modulation in mice. J. Sci. Food Agric. 103, 1749\u20131760 (2023).","journal-title":"J. Sci. Food Agric."},{"key":"2345_CR160","doi-asserted-by":"publisher","first-page":"7087","DOI":"10.1002\/jsfa.12070","volume":"102","author":"C Wan","year":"2022","unstructured":"Wan, C. et al. Exopolysaccharide from Lactobacillus rhamnosus ZFM231 alleviates DSS-induced colitis in mice by regulating gut microbiota. J. Sci. Food Agric. 102, 7087\u20137097 (2022).","journal-title":"J. Sci. Food Agric."},{"key":"2345_CR161","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202200450","volume":"67","author":"Z Ren","year":"2023","unstructured":"Ren, Z. et al. Hericium erinaceus mycelium-Derived Polysaccharide Alleviates Ulcerative Colitis and Modulates Gut Microbiota in Cynomolgus Monkeys. Mol. Nutr. Food Res. 67, e2200450 (2023).","journal-title":"Mol. Nutr. Food Res."},{"key":"2345_CR162","doi-asserted-by":"crossref","unstructured":"Talib, N. et al. Isolation and Characterization of Lactobacillus spp. from Kefir Samples in Malaysia. Molecules. 24, 2606 (2019).","DOI":"10.3390\/molecules24142606"},{"key":"2345_CR163","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1021\/acs.jafc.2c06894","volume":"71","author":"Q Cui","year":"2023","unstructured":"Cui, Q. et al. Bifidobacterium bifidum Ameliorates DSS-induced colitis in mice by regulating AHR\/NRF2\/NLRP3 inflammasome pathways through Indole-3-lactic acid production. J. Agric. Food Chem. 71, 1970\u20131981 (2023).","journal-title":"J. Agric. Food Chem."},{"key":"2345_CR164","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1021\/acs.jafc.2c07090","volume":"71","author":"J Wu","year":"2023","unstructured":"Wu, J. et al. Bifidobacterium longum CCFM1206 Promotes the Biotransformation of Glucoraphanin to sulforaphane that contributes to amelioration of dextran-sulfate-sodium-induced colitis in mice. J. Agric. Food Chem. 71, 1100\u20131112 (2023).","journal-title":"J. Agric. Food Chem."},{"key":"2345_CR165","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.7150\/thno.81571","volume":"13","author":"W Zhou","year":"2023","unstructured":"Zhou, W. et al. Disulfiram with Cu(2+) alleviates dextran sulfate sodium-induced ulcerative colitis in mice. Theranostics 13, 2879\u20132895 (2023).","journal-title":"Theranostics"},{"key":"2345_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2023.114009","volume":"180","author":"W Chen","year":"2023","unstructured":"Chen, W. et al. Fermentation patterns of prebiotics fructooligosaccharides-SCFA esters inoculated with fecal microbiota from ulcerative colitis patients. Food Chem. Toxicol. 180, 114009 (2023).","journal-title":"Food Chem. Toxicol."},{"key":"2345_CR167","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1039\/D1FO02218K","volume":"13","author":"H Lan","year":"2022","unstructured":"Lan, H. et al. Bifidobacterium lactis BL-99 protects mice with osteoporosis caused by colitis via gut inflammation and gut microbiota regulation. Food Funct. 13, 1482\u20131494 (2022).","journal-title":"Food Funct."},{"key":"2345_CR168","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1028919","volume":"13","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. In vivo evidence of the prevents DSS-induced colitis of Lactiplantibacillus plantarum L15. Front. Microbiol. 13, 1028919 (2022).","journal-title":"Front. Microbiol."},{"key":"2345_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1137701","volume":"14","author":"Q Liu","year":"2023","unstructured":"Liu, Q. et al. Alleviation of DSS-induced colitis in mice by a new-isolated Lactobacillus acidophilus C4. Front. Microbiol. 14, 1137701 (2023).","journal-title":"Front. Microbiol."},{"key":"2345_CR170","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1039\/D1FO03337A","volume":"13","author":"S Kang","year":"2022","unstructured":"Kang, S. et al. Butyl-fructooligosaccharides modulate gut microbiota in healthy mice and ameliorate ulcerative colitis in a DSS-induced model. Food Funct. 13, 1834\u20131845 (2022).","journal-title":"Food Funct."},{"key":"2345_CR171","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s00018-022-04471-3","volume":"79","author":"L Huang","year":"2022","unstructured":"Huang, L. et al. 5-Aminosalicylic acid ameliorates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota and bile acid metabolism. Cell Mol. Life Sci. 79, 460 (2022).","journal-title":"Cell Mol. Life Sci."},{"key":"2345_CR172","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","volume":"19","author":"PD Cani","year":"2022","unstructured":"Cani, P. D. et al. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat. Rev. Gastroenterol. Hepatol. 19, 625\u2013637 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2345_CR173","doi-asserted-by":"crossref","unstructured":"Li, N. et al. Cooperative interactions between Veillonella ratti and Lactobacillus acidophilus ameliorate DSS-induced ulcerative colitis in mice. Food Funct. 14, 10475\u201310492 (2023).","DOI":"10.1039\/D3FO03898J"},{"key":"2345_CR174","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1039\/D2FO03493J","volume":"14","author":"L Xue","year":"2023","unstructured":"Xue, L. et al. The effects of live and pasteurized Akkermansia muciniphila on DSS-induced ulcerative colitis, gut microbiota, and metabolomics in mice. Food Funct. 14, 4632\u20134646 (2023).","journal-title":"Food Funct."},{"key":"2345_CR175","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00641-22","volume":"10","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Bacillus coagulans in combination with chitooligosaccharides regulates gut microbiota and ameliorates the DSS-Induced colitis in mice. Microbiol Spectr. 10, e0064122 (2022).","journal-title":"Microbiol Spectr."},{"key":"2345_CR176","doi-asserted-by":"crossref","unstructured":"Ren, Y. et al. Low weight polysaccharide of hericium erinaceus ameliorates colitis via inhibiting the NLRP3 inflammasome activation in association with gut microbiota modulation. Nutrients. 15, (2023).","DOI":"10.3390\/nu15030739"},{"key":"2345_CR177","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1039\/D1FO03815J","volume":"13","author":"J Fang","year":"2022","unstructured":"Fang, J. et al. EPA and DHA differentially coordinate the crosstalk between host and gut microbiota and block DSS-induced colitis in mice by a reinforced colonic mucus barrier. Food Funct. 13, 4399\u20134420 (2022).","journal-title":"Food Funct."},{"key":"2345_CR178","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00730-21","volume":"9","author":"S Qu","year":"2021","unstructured":"Qu, S. et al. Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by NLRP3 Activation. Microbiol. Spectr. 9, e0073021 (2021).","journal-title":"Microbiol. Spectr."},{"key":"2345_CR179","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1007\/s10620-021-07131-x","volume":"67","author":"T Nakashima","year":"2022","unstructured":"Nakashima, T. et al. Novel gut microbiota modulator, which markedly increases akkermansia muciniphila occupancy, ameliorates experimental colitis in Rats. Dig. Dis. Sci. 67, 2899\u20132911 (2022).","journal-title":"Dig. Dis. Sci."},{"key":"2345_CR180","doi-asserted-by":"crossref","unstructured":"Hu, X. et al. Improvement of ulcerative colitis by aspartate via ripk pathway modulation and gut microbiota composition in mice. Nutrients. 14, 3707 (2022).","DOI":"10.3390\/nu14183707"},{"key":"2345_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2021.110568","volume":"148","author":"B Pang","year":"2021","unstructured":"Pang, B. et al. Vitamin A supplementation ameliorates ulcerative colitis in gut microbiota-dependent manner. Food Res. Int. 148, 110568 (2021).","journal-title":"Food Res. Int."},{"key":"2345_CR182","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.660598","volume":"8","author":"S Wang","year":"2021","unstructured":"Wang, S. et al. Bovine lactoferrin protects dextran sulfate sodium salt mice against inflammation and impairment of colonic epithelial barrier by regulating gut microbial structure and metabolites. Front. Nutr. 8, 660598 (2021).","journal-title":"Front. Nutr."},{"key":"2345_CR183","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nrmicro2298","volume":"8","author":"O Tenaillon","year":"2010","unstructured":"Tenaillon, O., Skurnik, D., Picard, B. & Denamur, E. The population genetics of commensal Escherichia coli. Nat. Rev. Microbiol 8, 207\u2013217 (2010).","journal-title":"Nat. Rev. Microbiol"},{"key":"2345_CR184","doi-asserted-by":"crossref","unstructured":"Dai, W. et al. Discovery of bacteroides uniformis F18-22 as a safe and novel probiotic bacterium for the treatment of ulcerative colitis from the healthy human colon. Int. J. Mol. Sci. 24, 14669 (2023).","DOI":"10.3390\/ijms241914669"},{"key":"2345_CR185","doi-asserted-by":"crossref","unstructured":"Cevallos, S. A. et al. 5-Aminosalicylic acid ameliorates colitis and checks dysbiotic Escherichia coli expansion by activating PPAR-\u03b3 signaling in the intestinal epithelium. mBio. 12, 10\u20131128 (2021).","DOI":"10.1128\/mBio.03227-20"},{"key":"2345_CR186","doi-asserted-by":"publisher","first-page":"12022","DOI":"10.1039\/D1FO02405A","volume":"12","author":"X Dou","year":"2021","unstructured":"Dou, X. et al. Lactobacillus casei ATCC 393 and it\u2019s metabolites alleviate dextran sulphate sodium-induced ulcerative colitis in mice through the NLRP3-(Caspase-1)\/IL-1\u03b2 pathway. Food Funct. 12, 12022\u201312035 (2021).","journal-title":"Food Funct."},{"key":"2345_CR187","doi-asserted-by":"crossref","unstructured":"Hu, Q. et al. Anti-inflammatory, barrier maintenance, and gut microbiome modulation effects of Saccharomyces cerevisiae QHNLD8L1 on DSS-induced ulcerative colitis in mice. Int. J. Mol. Sci. 24, 6721 (2023).","DOI":"10.3390\/ijms24076721"},{"key":"2345_CR188","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1113\/EP090635","volume":"108","author":"M Shao","year":"2023","unstructured":"Shao, M., Liu, J. & Luo, H. Colitis aggravated by Mrgprb2 knockout is associated with altered immune response, intestinal barrier function and gut microbiota. Exp. Physiol. 108, 63\u201375 (2023).","journal-title":"Exp. Physiol."},{"key":"2345_CR189","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s00203-023-03570-4","volume":"205","author":"S Sha","year":"2023","unstructured":"Sha, S. et al. Adherent-invasive Escherichia coli LF82 aggravated intestinal inflammation in colitis mice by affecting the gut microbiota and Th17\/Treg cell differentiation balance. Arch. Microbiol. 205, 218 (2023).","journal-title":"Arch. Microbiol."},{"key":"2345_CR190","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01368-22","volume":"10","author":"L Ma","year":"2022","unstructured":"Ma, L. et al. Clostridium butyricum and its derived extracellular vesicles modulate gut homeostasis and ameliorate acute experimental colitis. Microbiol. Spectr. 10, e0136822 (2022).","journal-title":"Microbiol. Spectr."},{"key":"2345_CR191","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1093\/ecco-jcc\/jjab094","volume":"15","author":"H Ni","year":"2021","unstructured":"Ni, H. et al. SATB2 defect promotes colitis and colitis-associated colorectal cancer by impairing Cl-\/HCO3- exchange and homeostasis of gut microbiota. J. Crohns Colitis 15, 2088\u20132102 (2021).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR192","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41579-018-0129-6","volume":"17","author":"CA Brennan","year":"2019","unstructured":"Brennan, C. A. & Garrett, W. S. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium. Nat. Rev. Microbiol. 17, 156\u2013166 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"2345_CR193","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/JPER.22-0205","volume":"94","author":"S Lin","year":"2023","unstructured":"Lin, S. et al. Fusobacterium nucleatum aggravates ulcerative colitis through promoting gut microbiota dysbiosis and dysmetabolism. J. Periodontol. 94, 405\u2013418 (2023).","journal-title":"J. Periodontol."},{"key":"2345_CR194","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1902718","volume":"13","author":"L Liu","year":"2021","unstructured":"Liu, L. et al. Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway. Gut Microbes 13, 1\u201320 (2021).","journal-title":"Gut Microbes"},{"key":"2345_CR195","doi-asserted-by":"crossref","unstructured":"Cheng, S. et al. Lactobacillus gasseri JM1 Isolated from Infant Feces Alleviates Colitis in Mice via Protecting the Intestinal Barrier. Nutrients. 15, 139 (2022).","DOI":"10.3390\/nu15010139"},{"key":"2345_CR196","doi-asserted-by":"publisher","first-page":"6109","DOI":"10.3748\/wjg.v28.i43.6109","volume":"28","author":"JL Wang","year":"2022","unstructured":"Wang, J. L. et al. Differential analysis of intestinal microbiota and metabolites in mice with dextran sulfate sodium-induced colitis. World J. Gastroenterol. 28, 6109\u20136130 (2022).","journal-title":"World J. Gastroenterol."},{"key":"2345_CR197","doi-asserted-by":"crossref","unstructured":"Xu, X. et al. Both saccharomyces boulardii and its postbiotics alleviate dextran sulfate sodium-induced colitis in mice, association with modulating inflammation and intestinal microbiota. Nutrients. 15, 1484 (2023).","DOI":"10.3390\/nu15061484"},{"key":"2345_CR198","doi-asserted-by":"publisher","first-page":"2683465","DOI":"10.1155\/2021\/2683465","volume":"2021","author":"W He","year":"2021","unstructured":"He, W., Ni, W. & Zhao, J. Enterococcus faecium Alleviates Gut Barrier Injury in C57BL\/6 mice with dextran sulfate sodium-induced ulcerative colitis. Gastroenterol. Res Pract. 2021, 2683465 (2021).","journal-title":"Gastroenterol. Res Pract."},{"key":"2345_CR199","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.3390\/nu13103319","volume":"13","author":"L Tong","year":"2021","unstructured":"Tong, L. et al. Lactobacillus rhamnosus GG derived extracellular vesicles modulate gut microbiota and attenuate inflammatory in DSS-induced colitis mice. Nutrients 13, 3319 (2021).","journal-title":"Nutrients"},{"key":"2345_CR200","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.cgh.2024.05.017","volume":"23","author":"C Caenepeel","year":"2025","unstructured":"Caenepeel, C. et al. Rigorous donor selection for fecal microbiota transplantation in active ulcerative colitis: key lessons from a randomized controlled trial halted for futility. Clin. Gastroenterol. Hepatol. 23, 621\u2013631.e627 (2025).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2345_CR201","doi-asserted-by":"publisher","first-page":"711055","DOI":"10.3389\/fcimb.2021.711055","volume":"11","author":"SC Bokoliya","year":"2021","unstructured":"Bokoliya, S. C., Dorsett, Y., Panier, H. & Zhou, Y. Procedures for fecal microbiota transplantation in murine microbiome studies. Front. Cell Infect. Microbiol. 11, 711055 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"2345_CR202","doi-asserted-by":"publisher","first-page":"247","DOI":"10.33073\/pjm-2023-025","volume":"72","author":"S Shang","year":"2023","unstructured":"Shang, S. et al. The impacts of fecal microbiota transplantation from same sex on the symptoms of ulcerative colitis patients. Pol. J. Microbiol. 72, 247\u2013268 (2023).","journal-title":"Pol. J. Microbiol."},{"key":"2345_CR203","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.658292","volume":"12","author":"HM Xu","year":"2021","unstructured":"Xu, H. M. et al. Cross-talk between butyric acid and gut microbiota in ulcerative colitis following fecal microbiota transplantation. Front. Microbiol.12, 658292 (2021).","journal-title":"Front. Microbiol."},{"key":"2345_CR204","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.3748\/wjg.v27.i21.2834","volume":"27","author":"X Wen","year":"2021","unstructured":"Wen, X. et al. Fecal microbiota transplantation ameliorates experimental colitis via gut microbiota and T-cell modulation. World J. Gastroenterol. 27, 2834\u20132849 (2021).","journal-title":"World J. Gastroenterol."},{"key":"2345_CR205","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/pathogens10020152","volume":"10","author":"P Adamkova","year":"2021","unstructured":"Adamkova, P. et al. Single Donor FMT Reverses Microbial\/Immune Dysbiosis and Induces Clinical Remission in a Rat Model of Acute Colitis. Pathogens 10, 152 (2021).","journal-title":"Pathogens"},{"key":"2345_CR206","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1177\/15353702211006044","volume":"246","author":"L Zhang","year":"2021","unstructured":"Zhang, L. et al. Treatment and mechanism of fecal microbiota transplantation in mice with experimentally induced ulcerative colitis. Exp. Biol. Med. 246, 1563\u20131575 (2021).","journal-title":"Exp. Biol. Med."},{"key":"2345_CR207","doi-asserted-by":"crossref","unstructured":"Qian, X. et al. Fecal microbiota transplantation combined with prebiotics ameliorates ulcerative colitis in mice. Fut. Microbiol. 18, 1251\u20131263 (2023).","DOI":"10.2217\/fmb-2023-0001"},{"key":"2345_CR208","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105803","volume":"173","author":"D Li","year":"2022","unstructured":"Li, D. et al. Fecal microbiota transplantation improves intestinal inflammation in mice with ulcerative colitis by modulating intestinal flora composition and down-regulating NF-kB signaling pathway. Micro Pathog. 173, 105803 (2022).","journal-title":"Micro Pathog."},{"key":"2345_CR209","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.836542","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Human fecal microbiota transplantation reduces the susceptibility to dextran sulfate sodium-induced germ-free mouse colitis. Front. Immunol. 13, 836542 (2022).","journal-title":"Front. Immunol."},{"key":"2345_CR210","first-page":"48","volume":"26","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Albiflorin alleviates DSS-induced ulcerative colitis in mice by reducing inflammation and oxidative stress. Iran. J. Basic Med. Sci. 26, 48\u201356 (2023).","journal-title":"Iran. J. Basic Med. Sci."},{"key":"2345_CR211","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence, T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb. Perspect. Biol. 1, a001651 (2009).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2345_CR212","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","volume":"132","author":"MS Hayden","year":"2008","unstructured":"Hayden, M. S. & Ghosh, S. Shared principles in NF-kappaB signaling. Cell 132, 344\u2013362 (2008).","journal-title":"Cell"},{"key":"2345_CR213","doi-asserted-by":"publisher","first-page":"8044","DOI":"10.18632\/aging.204953","volume":"15","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. The alleviating effect and mechanism of GLP-1 on ulcerative colitis. Aging15, 8044\u20138060 (2023).","journal-title":"Aging"},{"key":"2345_CR214","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154490","volume":"108","author":"C Liu","year":"2023","unstructured":"Liu, C. et al. Angelica oil restores the intestinal barrier function by suppressing S100A8\/A9 signalling in mice with ulcerative colitis. Phytomedicine 108, 154490 (2023).","journal-title":"Phytomedicine"},{"key":"2345_CR215","doi-asserted-by":"crossref","unstructured":"Dou, W. et al. The alleviating effects and mechanisms of betaine on dextran sulfate sodium-induced colitis in mice. Mol Nutr. Food Res. 67, 2300376, (2023).","DOI":"10.1002\/mnfr.202300376"},{"key":"2345_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2023.213520","volume":"152","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. Bioactive glass in the treatment of ulcerative colitis to regulate the TLR4 \/ MyD88 \/ NF-\u03baB pathway. Biomater. Adv. 152, 213520 (2023).","journal-title":"Biomater. Adv."},{"key":"2345_CR217","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03843-0","volume":"12","author":"S Chen","year":"2021","unstructured":"Chen, S. et al. Epithelial PBLD attenuates intestinal inflammatory response and improves intestinal barrier function by inhibiting NF-\u03baB signaling. Cell Death Dis. 12, 563 (2021).","journal-title":"Cell Death Dis."},{"key":"2345_CR218","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41423-021-00810-9","volume":"19","author":"B Wu","year":"2022","unstructured":"Wu, B. et al. The deubiquitinase OTUD1 inhibits colonic inflammation by suppressing RIPK1-mediated NF-\u03baB signaling. Cell Mol. Immunol. 19, 276\u2013289 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"2345_CR219","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107920","volume":"99","author":"M Li","year":"2021","unstructured":"Li, M. et al. IL-6 downregulates hepatic carboxylesterases via NF-\u03baB activation in dextran sulfate sodium-induced colitis. Int. Immunopharmacol. 99, 107920 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"2345_CR220","doi-asserted-by":"publisher","first-page":"92","DOI":"10.15586\/aei.v51i1.762","volume":"51","author":"T Qiu","year":"2023","unstructured":"Qiu, T., Lv, Y., Niu, L. & Zhang, Y. Knockdown of TRIM8 alleviates dextran sulfate sodium-induced colitis in mice by inhibiting the NF-\u03baB signaling pathway. Allergol. Immunopathol.51, 92\u201397 (2023).","journal-title":"Allergol. Immunopathol."},{"key":"2345_CR221","doi-asserted-by":"crossref","unstructured":"Moon, H. J., Cha, Y. S. & Kim, K. A. Blackcurrant Alleviates Dextran Sulfate Sodium (DSS)-induced colitis in mice. Foods. 12, 1073 (2023).","DOI":"10.3390\/foods12051073"},{"key":"2345_CR222","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.3390\/molecules28072982","volume":"28","author":"V Raj","year":"2023","unstructured":"Raj, V. et al. Cis-nerolidol inhibits MAP kinase and NF-\u03baB signaling pathways and prevents epithelial tight junction dysfunction in colon inflammation: in vivo and in vitro studies. Molecules 28, 2982 (2023).","journal-title":"Molecules"},{"key":"2345_CR223","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18137","volume":"9","author":"Y He","year":"2023","unstructured":"He, Y. et al. Citrus peel polyphenols alleviate intestinal inflammation in mice with dextran sulfate sodium-induced acute colitis. Heliyon 9, e18137 (2023).","journal-title":"Heliyon"},{"key":"2345_CR224","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121820","volume":"327","author":"RN El Mahdy","year":"2023","unstructured":"El Mahdy, R. N. et al. Eicosapentaenoic acid mitigates ulcerative colitis-induced by acetic acid through modulation of NF-\u03baB and TGF-\u03b2\/ EGFR signaling pathways. Life Sci. 327, 121820 (2023).","journal-title":"Life Sci."},{"key":"2345_CR225","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109621","volume":"115","author":"AA Abdelsameea","year":"2023","unstructured":"Abdelsameea, A. A. et al. Icosapent ethyl alleviates acetic acid-induced ulcerative colitis via modulation of SIRT1 signaling pathway in rats. Int. Immunopharmacol. 115, 109621 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"2345_CR226","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1007\/s10787-023-01277-y","volume":"31","author":"M Ghasemi-Dehnoo","year":"2023","unstructured":"Ghasemi-Dehnoo, M. et al. Ferulic acid ameliorates ulcerative colitis in a rat model via the inhibition of two LPS-TLR4-NF-\u03baB and NF-\u03baB-INOS-NO signaling pathways and thus alleviating the inflammatory, oxidative and apoptotic conditions in the colon tissue. Inflammopharmacology 31, 2587\u20132597 (2023).","journal-title":"Inflammopharmacology"},{"key":"2345_CR227","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302607","volume":"10","author":"Q Fan","year":"2023","unstructured":"Fan, Q. et al. Hyper \u03b12,6-Sialylation Promotes CD4(+) T-Cell Activation and induces the occurrence of ulcerative colitis. Adv. Sci.10, e2302607 (2023).","journal-title":"Adv. Sci."},{"key":"2345_CR228","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1089\/jmf.2021.K.0150","volume":"25","author":"SY Lee","year":"2022","unstructured":"Lee, S. Y. et al. Bifidobacterium bifidum BGN4 paraprobiotic supplementation alleviates experimental colitis by maintaining gut barrier and suppressing nuclear factor Kappa B activation signaling molecules. J. Med. Food 25, 146\u2013157 (2022).","journal-title":"J. Med. Food"},{"key":"2345_CR229","doi-asserted-by":"publisher","first-page":"935792","DOI":"10.3389\/fmicb.2022.935792","volume":"13","author":"B Liu","year":"2022","unstructured":"Liu, B., Yang, L., Wu, Y. & Zhao, X. Protective effect of Limosilactobacillus fermentum HFY06 on dextran sulfate sodium-induced colitis in mice. Front. Microbiol. 13, 935792 (2022).","journal-title":"Front. Microbiol."},{"key":"2345_CR230","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.2147\/JIR.S344695","volume":"14","author":"F Li","year":"2021","unstructured":"Li, F. et al. A mixture of Lactobacillus fermentum HFY06 and Arabinoxylan Ameliorates Dextran sulfate sodium-induced acute ulcerative colitis in mice. J. Inflamm. Res. 14, 6575\u20136585 (2021).","journal-title":"J. Inflamm. Res."},{"key":"2345_CR231","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.705172","volume":"8","author":"JJ Miklavcic","year":"2021","unstructured":"Miklavcic, J. J. et al. Ganglioside alters phospholipase trafficking, inhibits NF-\u03baB assembly, and protects tight junction integrity. Front. Nutr. 8, 705172 (2021).","journal-title":"Front. Nutr."},{"key":"2345_CR232","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.760999","volume":"12","author":"J Ren","year":"2021","unstructured":"Ren, J. et al. Inhibitor of differentiation-2 Protein Ameliorates DSS-Induced Ulcerative Colitis By Inhibiting NF-\u03baB Activation In Neutrophils. Front. Immunol. 12, 760999 (2021).","journal-title":"Front. Immunol."},{"key":"2345_CR233","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154702","volume":"112","author":"SN Yuan","year":"2023","unstructured":"Yuan, S. N. et al. Improved colonic inflammation by nervonic acid via inhibition of NF-\u03baB signaling pathway of DSS-induced colitis mice. Phytomedicine 112, 154702 (2023).","journal-title":"Phytomedicine"},{"key":"2345_CR234","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176166","volume":"960","author":"HS Althagafy","year":"2023","unstructured":"Althagafy, H. S. et al. Canagliflozin ameliorates ulcerative colitis via regulation of TLR4\/MAPK\/NF-\u03baB and Nrf2\/PPAR-\u03b3\/SIRT1 signaling pathways. Eur. J. Pharm. 960, 176166 (2023).","journal-title":"Eur. J. Pharm."},{"key":"2345_CR235","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115669","volume":"259","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. Diclofenac and eugenol hybrid with enhanced anti-inflammatory activity through activating HO-1 and inhibiting NF-\u03baB pathway in vitro and in vivo. Eur. J. Med. Chem. 259, 115669 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"2345_CR236","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200749R","volume":"36","author":"S Cavalu","year":"2022","unstructured":"Cavalu, S. et al. Ambroxol, a mucolytic agent, boosts HO-1, suppresses NF-\u03baB, and decreases the susceptibility of the inflamed rat colon to apoptosis: a new treatment option for treating ulcerative colitis. FASEB J. 36, e22496 (2022).","journal-title":"FASEB J."},{"key":"2345_CR237","doi-asserted-by":"publisher","first-page":"887233","DOI":"10.3389\/fphar.2022.887233","volume":"13","author":"AM Abdelhamid","year":"2022","unstructured":"Abdelhamid, A. M. et al. Carbocisteine as a modulator of Nrf2\/HO-1 and NF\u03baB Interplay In Rats: New Inspiration For The Revival Of An Old Drug For Treating Ulcerative Colitis. Front. Pharm. 13, 887233 (2022).","journal-title":"Front. Pharm."},{"key":"2345_CR238","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115673","volume":"214","author":"EA Elhefnawy","year":"2023","unstructured":"Elhefnawy, E. A. et al. Genistein and\/or sulfasalazine ameliorate acetic acid-induced ulcerative colitis in rats via modulating INF-\u03b3\/JAK1\/STAT1\/IRF-1, TLR-4\/NF-\u03baB\/IL-6, and JAK2\/STAT3\/COX-2 crosstalk. Biochem. Pharm. 214, 115673 (2023).","journal-title":"Biochem. Pharm."},{"key":"2345_CR239","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1055\/a-1855-1491","volume":"72","author":"A Rashidian","year":"2022","unstructured":"Rashidian, A. et al. Buspirone Ameliorates Colon Inflammation in TNBS-induced rat acute colitis: the involvement of TLR4\/NF-kB pathway. Drug Res.72, 449\u2013456 (2022).","journal-title":"Drug Res."},{"key":"2345_CR240","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.904926","volume":"13","author":"P Luo","year":"2022","unstructured":"Luo, P. et al. Central administration of human opiorphin alleviates dextran sodium sulfate-induced colitis in mice through activation of the endogenous opioid system. Front. Pharm. 13, 904926 (2022).","journal-title":"Front. Pharm."},{"key":"2345_CR241","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s10787-022-01016-9","volume":"30","author":"GS El-Tanbouly","year":"2022","unstructured":"El-Tanbouly, G. S. & Abdelrahman, R. S. The emerging coloprotective effect of sildenafil against ulcerative colitis in rats via exerting counterbalance between NF-\u03baB signaling and Nrf-2\/HO-1 pathway. Inflammopharmacology 30, 1351\u20131362 (2022).","journal-title":"Inflammopharmacology"},{"key":"2345_CR242","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1135930","volume":"14","author":"H Gao","year":"2023","unstructured":"Gao, H. et al. Vitamin D3 alleviates inflammation in ulcerative colitis by activating the VDR-NLRP6 signaling pathway. Front. Immunol. 14, 1135930 (2023).","journal-title":"Front. Immunol."},{"key":"2345_CR243","doi-asserted-by":"publisher","first-page":"G837","DOI":"10.1152\/ajpgi.00061.2021","volume":"320","author":"G Xue","year":"2021","unstructured":"Xue, G. et al. Vitamin D\/VDR signaling inhibits colitis by suppressing HIF-1\u03b1 activation in colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 320, G837\u2013g846 (2021).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2345_CR244","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1093\/ecco-jcc\/jjab044","volume":"15","author":"I Chatterjee","year":"2021","unstructured":"Chatterjee, I. et al. Overexpression of Vitamin D receptor in intestinal epithelia protects against colitis via upregulating tight junction protein Claudin 15. J. Crohns Colitis 15, 1720\u20131736 (2021).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR245","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.apsb.2021.07.023","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Targeting PI3K\/AKT signaling for treatment of idiopathic pulmonary fibrosis. Acta Pharm. Sin. B 12, 18\u201332 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"2345_CR246","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","volume":"85","author":"L Yu","year":"2022","unstructured":"Yu, L., Wei, J. & Liu, P. Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin. Cancer Biol. 85, 69\u201394 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"2345_CR247","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3389\/fphar.2020.01036","volume":"11","author":"B Liu","year":"2020","unstructured":"Liu, B. et al. Kuijieyuan decoction improved intestinal barrier injury of ulcerative colitis by affecting TLR4-Dependent PI3K\/AKT\/NF-\u03baB oxidative and inflammatory signaling and gut microbiota. Front. Pharm. 11, 1036 (2020).","journal-title":"Front. Pharm."},{"key":"2345_CR248","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.jcmgh.2020.10.007","volume":"11","author":"C Zhang","year":"2021","unstructured":"Zhang, C. et al. Fibrinogen\/AKT\/Microfilament axis promotes colitis by enhancing vascular permeability. Cell Mol. Gastroenterol. Hepatol. 11, 683\u2013696 (2021).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"2345_CR249","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.632805","volume":"9","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Impaired barrier function and immunity in the colon of aldo-keto reductase 1B8 deficient mice. Front. Cell Dev. Biol. 9, 632805 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"2345_CR250","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1042\/CS20201438","volume":"135","author":"D Dou","year":"2021","unstructured":"Dou, D. et al. Oxytocin signalling in dendritic cells regulates immune tolerance in the intestine and alleviates DSS-induced colitis. Clin. Sci. 135, 597\u2013611 (2021).","journal-title":"Clin. Sci."},{"key":"2345_CR251","doi-asserted-by":"publisher","first-page":"121139","DOI":"10.1016\/j.lfs.2022.121139","volume":"311","author":"X Hou","year":"2022","unstructured":"Hou, X., Sang, Y. & Dong, L. The improved effect and its mechanism of phytic acid on DSS-induced UC mice. Life Sci. 311, 121139 (2022).","journal-title":"Life Sci."},{"key":"2345_CR252","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/iid3.435","volume":"9","author":"P Winkelmann","year":"2021","unstructured":"Winkelmann, P. et al. The PI3K pathway as a therapeutic intervention point in inflammatory bowel disease. Immun. Inflamm. Dis. 9, 804\u2013818 (2021).","journal-title":"Immun. Inflamm. Dis."},{"key":"2345_CR253","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/jgh.15676","volume":"37","author":"Y Azuma","year":"2022","unstructured":"Azuma, Y. et al. Deoxycholic acid delays the wound healing of colonic epithelial cells via transmembrane G-protein-coupled receptor 5. J. Gastroenterol. Hepatol. 37, 134\u2013143 (2022).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2345_CR254","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/bcpt.13720","volume":"130","author":"MN Makled","year":"2022","unstructured":"Makled, M. N., Serrya, M. S. & El-Sheakh, A. R. Fingolimod ameliorates acetic acid-induced ulcerative colitis: an insight into its modulatory impact on pro\/anti-inflammatory cytokines and AKT\/mTOR signalling. Basic Clin. Pharm. Toxicol. 130, 569\u2013580 (2022).","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"2345_CR255","doi-asserted-by":"crossref","unstructured":"Li, J. et al. Exploring the targets and molecular mechanisms of thalidomide in the treatment of ulcerative colitis: network pharmacology and experimental validation. Curr. Pharm. Des. 29, 2721\u20132737 (2023).","DOI":"10.2174\/0113816128272502231101114727"},{"key":"2345_CR256","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/jpp\/rgad013","volume":"75","author":"RE Mostafa","year":"2023","unstructured":"Mostafa, R. E. & Abdel-Rahman, R. F. Ezetimibe alleviates acetic acid-induced ulcerative colitis in rats: targeting the Akt\/NF-\u03baB\/STAT3\/CXCL10 signaling axis. J. Pharm. Pharm. 75, 533\u2013543 (2023).","journal-title":"J. Pharm. Pharm."},{"key":"2345_CR257","doi-asserted-by":"publisher","first-page":"107354","DOI":"10.1016\/j.intimp.2020.107354","volume":"92","author":"MR Fouad","year":"2021","unstructured":"Fouad, M. R., Salama, R. M., Zaki, H. F. & El-Sahar, A. E. Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K\/Akt\/NF\u03baB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Int. Immunopharmacol. 92, 107354 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"2345_CR258","doi-asserted-by":"publisher","first-page":"103833","DOI":"10.1016\/j.etap.2022.103833","volume":"91","author":"MS Zaghloul","year":"2022","unstructured":"Zaghloul, M. S., Elshal, M. & Abdelmageed, M. E. Preventive empagliflozin activity on acute acetic acid-induced ulcerative colitis in rats via modulation of SIRT-1\/PI3K\/AKT pathway and improving colon barrier. Environ. Toxicol. Pharm. 91, 103833 (2022).","journal-title":"Environ. Toxicol. Pharm."},{"key":"2345_CR259","doi-asserted-by":"crossref","unstructured":"Ikeda, Y., Tsuji, A. & Matsuda, S. Gut protective effect from newly isolated bacteria as probiotics against dextran sulfate sodium and carrageenan-induced ulcerative colitis. Microorganisms. 11, 1858 (2023).","DOI":"10.3390\/microorganisms11071858"},{"key":"2345_CR260","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal. Transduct. Target Ther. 7, 3 (2022).","journal-title":"Signal. Transduct. Target Ther."},{"key":"2345_CR261","doi-asserted-by":"publisher","first-page":"57","DOI":"10.47162\/RJME.64.1.07","volume":"64","author":"C Ozbey","year":"2023","unstructured":"Ozbey, C. & Aydemir, I. Investigation of distribution of GSK-3\u03b2 signal pathway by age groups in cases of ulcerative colitis. Rom. J. Morphol. Embryol. 64, 57\u201363 (2023).","journal-title":"Rom. J. Morphol. Embryol."},{"key":"2345_CR262","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.1007\/s10620-022-07542-4","volume":"67","author":"M Zhang","year":"2022","unstructured":"Zhang, M. et al. Conflicting effects of Wnt-5a in ulcerative colitis: you wnt some, you lose some. Dig. Dis. Sci. 67, 4599\u20134601 (2022).","journal-title":"Dig. Dis. Sci."},{"key":"2345_CR263","doi-asserted-by":"publisher","first-page":"dev199587","DOI":"10.1242\/dev.199587","volume":"149","author":"S Das","year":"2022","unstructured":"Das, S. et al. Colonic healing requires Wnt produced by epithelium as well as Tagln+ and Acta2+ stromal cells. Development 149, dev199587 (2022).","journal-title":"Development"},{"key":"2345_CR264","doi-asserted-by":"publisher","first-page":"4760","DOI":"10.1007\/s10620-022-07537-1","volume":"67","author":"K Uchiyama","year":"2022","unstructured":"Uchiyama, K. et al. Investigation on the inhibitory effect of Wnt-5a on colonic mucosal inflammation in patients with ulcerative colitis. Dig. Dis. Sci. 67, 4760\u20134769 (2022).","journal-title":"Dig. Dis. Sci."},{"key":"2345_CR265","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1039\/D0FO02308F","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. Differential effects of EPA and DHA on DSS-induced colitis in mice and possible mechanisms involved. Food Funct. 12, 1803\u20131817 (2021).","journal-title":"Food Funct."},{"key":"2345_CR266","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2022.110360","volume":"114","author":"Y Xu","year":"2022","unstructured":"Xu, Y. et al. MicroRNA-182-5p aggravates ulcerative colitis by inactivating the Wnt\/\u03b2-catenin signaling pathway through DNMT3A-mediated SMARCA5 methylation. Genomics 114, 110360 (2022).","journal-title":"Genomics"},{"key":"2345_CR267","doi-asserted-by":"publisher","first-page":"11210","DOI":"10.3390\/ijms231911210","volume":"23","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. Inhibition of GABA(A)R or Application of Lactobacillus casei Zhang Alleviates Ulcerative Colitis in Mice: GABA(A)R as a Potential Target for Intestinal Epithelial Renewal and Repair. Int J. Mol. Sci. 23, 11210 (2022).","journal-title":"Int J. Mol. Sci."},{"key":"2345_CR268","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1923910","volume":"10","author":"K Wang","year":"2021","unstructured":"Wang, K. et al. Cldn-7 deficiency promotes experimental colitis and associated carcinogenesis by regulating intestinal epithelial integrity. Oncoimmunology 10, 1923910 (2021).","journal-title":"Oncoimmunology"},{"key":"2345_CR269","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1007\/s11596-022-2564-x","volume":"42","author":"XQ Chen","year":"2022","unstructured":"Chen, X. Q. et al. CYP24A1 involvement in inflammatory factor regulation occurs via the Wnt signaling pathway. Curr. Med. Sci. 42, 1022\u20131032 (2022).","journal-title":"Curr. Med. Sci."},{"key":"2345_CR270","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig, S. & Shaw, R. J. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol. 19, 121\u2013135 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2345_CR271","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116888","volume":"318","author":"SM Pan","year":"2024","unstructured":"Pan, S. M. et al. Baitouweng decoction repairs the intestinal barrier in DSS-induced colitis mice via regulation of AMPK\/mTOR-mediated autophagy. J. Ethnopharmacol. 318, 116888 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"2345_CR272","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.3390\/nu14142864","volume":"14","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Alginate oligosaccharides ameliorate DSS-induced colitis through modulation of AMPK\/NF-\u03baB pathway and intestinal microbiota. Nutrients 14, 2864 (2022).","journal-title":"Nutrients"},{"key":"2345_CR273","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11302-022-09885-z","volume":"19","author":"MJ Wang","year":"2023","unstructured":"Wang, M. J. et al. P2Y1R and P2Y2R: potential molecular triggers in muscle regeneration. Purinergic Signal. 19, 305\u2013313 (2023).","journal-title":"Purinergic Signal."},{"key":"2345_CR274","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.7150\/ijbs.82302","volume":"19","author":"Q Huan","year":"2023","unstructured":"Huan, Q. et al. Activation of P2Y1R impedes intestinal mucosa repair during colitis. Int. J. Biol. Sci. 19, 4360\u20134375 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"2345_CR275","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/pin.13380","volume":"73","author":"A Li","year":"2023","unstructured":"Li, A. et al. Donepezil attenuates inflammation and apoptosis in ulcerative colitis via regulating LRP1\/AMPK\/NF-\u03baB signaling. Pathol. Int. 73, 549\u2013559 (2023).","journal-title":"Pathol. Int."},{"key":"2345_CR276","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s10787-021-00818-7","volume":"29","author":"MA El-Rous","year":"2021","unstructured":"El-Rous, M. A., Saber, S., Raafat, E. M. & Ahmed, A. A. E. Dapagliflozin, an SGLT2 inhibitor, ameliorates acetic acid-induced colitis in rats by targeting NF\u03baB\/AMPK\/NLRP3 axis. Inflammopharmacology 29, 1169\u20131185 (2021).","journal-title":"Inflammopharmacology"},{"key":"2345_CR277","doi-asserted-by":"publisher","first-page":"719984","DOI":"10.3389\/fphar.2021.719984","volume":"12","author":"ME Youssef","year":"2021","unstructured":"Youssef, M. E. et al. Interference with the AMPK\u03b1\/mTOR\/NLRP3 signaling and the IL-23\/IL-17 axis effectively protects against the dextran sulfate sodium intoxication in rats: a new paradigm in empagliflozin and metformin reprofiling for the management of ulcerative colitis. Front. Pharm. 12, 719984 (2021).","journal-title":"Front. Pharm."},{"key":"2345_CR278","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10787-020-00730-6","volume":"29","author":"S Saber","year":"2021","unstructured":"Saber, S. & El-Kader, E. M. A. Novel complementary coloprotective effects of metformin and MCC950 by modulating HSP90\/NLRP3 interaction and inducing autophagy in rats. Inflammopharmacology 29, 237\u2013251 (2021).","journal-title":"Inflammopharmacology"},{"key":"2345_CR279","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki, T. & Kawai, T. Toll-like receptor signaling pathways. Front. Immunol. 5, 461 (2014).","journal-title":"Front. Immunol."},{"key":"2345_CR280","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.1002\/ptr.7938","volume":"37","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. 20(S)- Protopanaxadiol saponins isolated from Panax notoginseng target the binding of HMGB1 to TLR4 against inflammation in experimental ulcerative colitis. Phytother. Res. 37, 4690\u20134705 (2023).","journal-title":"Phytother. Res."},{"key":"2345_CR281","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04370-22","volume":"11","author":"X Huang","year":"2023","unstructured":"Huang, X. et al. Clostridium butyricum and chitooligosaccharides in synbiotic combination ameliorate symptoms in a DSS-induced ulcerative colitis mouse model by modulating gut microbiota and enhancing intestinal barrier function. Microbiol. Spectr. 11, e0437022 (2023).","journal-title":"Microbiol. Spectr."},{"key":"2345_CR282","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1165667","volume":"14","author":"B Thapa","year":"2023","unstructured":"Thapa, B. et al. Cell-penetrating TLR inhibitor peptide alleviates ulcerative colitis by the functional modulation of macrophages. Front. Immunol. 14, 1165667 (2023).","journal-title":"Front. Immunol."},{"key":"2345_CR283","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.669747","volume":"12","author":"E Pastille","year":"2021","unstructured":"Pastille, E. et al. Inhibition of TLR4 signaling impedes tumor growth in colitis-associated colon cancer. Front. Immunol. 12, 669747 (2021).","journal-title":"Front. Immunol."},{"key":"2345_CR284","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.3748\/wjg.v29.i30.4657","volume":"29","author":"X Wen","year":"2023","unstructured":"Wen, X. et al. Fecal microbiota transplantation alleviates experimental colitis through the Toll-like receptor 4 signaling pathway. World J. Gastroenterol. 29, 4657\u20134670 (2023).","journal-title":"World J. Gastroenterol."},{"key":"2345_CR285","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.822020","volume":"9","author":"Q Yao","year":"2022","unstructured":"Yao, Q. et al. 2\u2019-Fucosyllactose ameliorates inflammatory bowel disease by modulating gut microbiota and promoting MUC2 expression. Front. Nutr. 9, 822020 (2022).","journal-title":"Front. Nutr."},{"key":"2345_CR286","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119123","volume":"270","author":"S Saber","year":"2021","unstructured":"Saber, S. et al. BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R\/NLRP3 and MyD88\/NF-\u03baB signaling in DSS-induced colitis in rats. Life Sci. 270, 119123 (2021).","journal-title":"Life Sci."},{"key":"2345_CR287","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12876-022-02208-x","volume":"22","author":"C Duan","year":"2022","unstructured":"Duan, C. et al. RIP3 knockdown inhibits necroptosis of human intestinal epithelial cells via TLR4\/MyD88\/NF-\u03baB signaling and ameliorates murine colitis. BMC Gastroenterol. 22, 137 (2022).","journal-title":"BMC Gastroenterol."},{"key":"2345_CR288","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1089622","volume":"14","author":"M Zhang","year":"2023","unstructured":"Zhang, M. et al. Exploration of the shared pathways and common biomarker PAN3 in ankylosing spondylitis and ulcerative colitis using integrated bioinformatics analysis. Front. Immunol. 14, 1089622 (2023).","journal-title":"Front. Immunol."},{"key":"2345_CR289","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.700217","volume":"12","author":"Z Chen","year":"2021","unstructured":"Chen, Z. et al. Lactobacillus fermentum ZS40 ameliorates inflammation in mice with ulcerative colitis induced by dextran sulfate sodium. Front. Pharm. 12, 700217 (2021).","journal-title":"Front. Pharm."},{"key":"2345_CR290","doi-asserted-by":"publisher","first-page":"235","DOI":"10.33549\/physiolres.934937","volume":"72","author":"Y Ma","year":"2023","unstructured":"Ma, Y. et al. Anti-inflammatory effect of Irisin on LPS-stimulated macrophages through inhibition of MAPK pathway. Physiol. Res. 72, 235\u2013249 (2023).","journal-title":"Physiol. Res."},{"key":"2345_CR291","doi-asserted-by":"publisher","first-page":"311","DOI":"10.5603\/FHC.a2022.0029","volume":"60","author":"X Ye","year":"2022","unstructured":"Ye, X., Xu, H. & Xu, Y. Dexmedetomidine alleviates intestinal barrier dysfunction and inflammatory response in mice via suppressing TLR4\/MyD88\/NF-\u03baB signaling in an experimental model of ulcerative colitis. Folia Histochem Cytobiol. 60, 311\u2013322 (2022).","journal-title":"Folia Histochem Cytobiol."},{"key":"2345_CR292","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/fcp.12642","volume":"35","author":"P Dejban","year":"2021","unstructured":"Dejban, P. et al. Anti-inflammatory effect of amitriptyline in a rat model of acetic acid-induced colitis: the involvement of the TLR4\/NF-kB signaling pathway. Fundam. Clin. Pharm. 35, 843\u2013851 (2021).","journal-title":"Fundam. Clin. Pharm."},{"key":"2345_CR293","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.777147","volume":"12","author":"H Hao","year":"2021","unstructured":"Hao, H. et al. Effect of extracellular vesicles derived from lactobacillus plantarum Q7 on gut microbiota and ulcerative colitis in mice. Front. Immunol. 12, 777147 (2021).","journal-title":"Front. Immunol."},{"key":"2345_CR294","doi-asserted-by":"publisher","first-page":"872","DOI":"10.17305\/bjbms.2022.7348","volume":"22","author":"B Yan","year":"2022","unstructured":"Yan, B. et al. Inhibition of IRAK 1\/4 alleviates colitis by inhibiting TLR4\/ NF-\u03baB pathway and protecting the intestinal barrier. Bosn. J. Basic Med. Sci. 22, 872\u2013881 (2022).","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"2345_CR295","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1093\/ecco-jcc\/jjab086","volume":"15","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. MTDH promotes intestinal inflammation by positively regulating TLR signalling. J. Crohns Colitis 15, 2103\u20132117 (2021).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR296","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1053\/j.gastro.2020.10.031","volume":"160","author":"JF Burgue\u00f1o","year":"2021","unstructured":"Burgue\u00f1o, J. F. et al. Epithelial TLR4 signaling activates DUOX2 to induce microbiota-driven tumorigenesis. Gastroenterology 160, 797\u2013808.e796 (2021).","journal-title":"Gastroenterology"},{"key":"2345_CR297","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.206","volume":"7","author":"Y Xing","year":"2016","unstructured":"Xing, Y., Cao, R. & Hu, H. M. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles). Cell Death Dis. 7, e2322 (2016).","journal-title":"Cell Death Dis."},{"key":"2345_CR298","doi-asserted-by":"crossref","unstructured":"Feng, W. et al. Anemoside B4 ameliorates dextran sulfate sodium (DSS)-induced colitis through inhibiting NLRP3 inflammasome and modulating gut microbiota. Eur. J. Pharmacol. 963, 176164, (2023).","DOI":"10.1016\/j.ejphar.2023.176164"},{"key":"2345_CR299","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.semcancer.2022.08.003","volume":"86","author":"GL Wong","year":"2022","unstructured":"Wong, G. L., Manore, S. G., Doheny, D. L. & Lo, H. W. STAT family of transcription factors in breast cancer: pathogenesis and therapeutic opportunities and challenges. Semin. Cancer Biol. 86, 84\u2013106 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"2345_CR300","doi-asserted-by":"publisher","first-page":"100544","DOI":"10.1016\/j.jaim.2022.100544","volume":"14","author":"T Prakash","year":"2023","unstructured":"Prakash, T. & Janadri, S. Anti-inflammatory effect of wedelolactone on DSS induced colitis in rats: IL-6\/STAT3 signaling pathway. J. Ayurveda Integr. Med. 14, 100544 (2023).","journal-title":"J. Ayurveda Integr. Med."},{"key":"2345_CR301","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111042","volume":"125","author":"M Wan","year":"2023","unstructured":"Wan, M. et al. 5-HT induces regulatory B cells in fighting against inflammation-driven ulcerative colitis. Int. Immunopharmacol. 125, 111042 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"2345_CR302","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.molimm.2023.09.009","volume":"163","author":"S Liu","year":"2023","unstructured":"Liu, S. et al. 3, 3\u2019-diindolylmethane, a natural aryl hydrocarbon receptor agonist, alleviates ulcerative colitis by enhancing \u201cglycolysis-lactate-STAT3\u2033 and TIP60 signals-mediated Treg differentiation. Mol. Immunol. 163, 147\u2013162 (2023).","journal-title":"Mol. Immunol."},{"key":"2345_CR303","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41392-023-01648-5","volume":"8","author":"HY Peng","year":"2023","unstructured":"Peng, H. Y. et al. Control of CD4(+) T cells to restrain inflammatory diseases via eukaryotic elongation factor 2 kinase. Signal. Transduct. Target Ther. 8, 415 (2023).","journal-title":"Signal. Transduct. Target Ther."},{"key":"2345_CR304","doi-asserted-by":"publisher","first-page":"119433","DOI":"10.1016\/j.lfs.2021.119433","volume":"276","author":"FEM Ali","year":"2021","unstructured":"Ali, F. E. M. et al. Regulation of IL-6\/STAT-3\/Wnt axis by nifuroxazide dampens colon ulcer in acetic acid-induced ulcerative colitis model: novel mechanistic insight. Life Sci. 276, 119433 (2021).","journal-title":"Life Sci."},{"key":"2345_CR305","doi-asserted-by":"crossref","unstructured":"Xu, Z. et al. Beneficial effects of hordenine on a model of ulcerative colitis. Molecules. 28, 2834 (2023).","DOI":"10.3390\/molecules28062834"},{"key":"2345_CR306","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1002\/JLB.4A0122-068R","volume":"112","author":"AR Cannon","year":"2022","unstructured":"Cannon, A. R., Shim, E. H., Kuprys, P. V. & Choudhry, M. A. IL-22 and Lactobacillus delbrueckii mitigate alcohol-induced exacerbation of DSS-induced colitis. J. Leukoc. Biol. 112, 1471\u20131484 (2022).","journal-title":"J. Leukoc. Biol."},{"key":"2345_CR307","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/fcp.12563","volume":"35","author":"NA El-Mahdy","year":"2021","unstructured":"El-Mahdy, N. A., El-Sayad, M. E., El-Kadem, A. H. & Abu-Risha, S. E. Targeting IL-10, ZO-1 gene expression and IL-6\/STAT-3 trans-signaling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuates progression of oxazolone-induced colitis. Fundam. Clin. Pharm. 35, 143\u2013155 (2021).","journal-title":"Fundam. Clin. Pharm."},{"key":"2345_CR308","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1002\/tox.23837","volume":"38","author":"Z He","year":"2023","unstructured":"He, Z., Liu, J. & Liu, Y. Daphnetin attenuates intestinal inflammation, oxidative stress, and apoptosis in ulcerative colitis via inhibiting REG3A-dependent JAK2\/STAT3 signaling pathway. Environ. Toxicol. 38, 2132\u20132142 (2023).","journal-title":"Environ. Toxicol."},{"key":"2345_CR309","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13287-021-02232-w","volume":"12","author":"T Yu","year":"2021","unstructured":"Yu, T. et al. Extracellular vesicles derived from EphB2-overexpressing bone marrow mesenchymal stem cells ameliorate DSS-induced colitis by modulating immune balance. Stem Cell Res. Ther. 12, 181 (2021).","journal-title":"Stem Cell Res. Ther."},{"key":"2345_CR310","doi-asserted-by":"publisher","first-page":"121596","DOI":"10.1016\/j.lfs.2023.121596","volume":"321","author":"M Shalaby","year":"2023","unstructured":"Shalaby, M., Abdelaziz, R. R., Ghoneim, H. A. & Suddek, G. M. Imatinib mitigates experimentally-induced ulcerative colitis: possible contribution of NF-kB\/JAK2\/STAT3\/COX2 signaling pathway. Life Sci. 321, 121596 (2023).","journal-title":"Life Sci."},{"key":"2345_CR311","doi-asserted-by":"publisher","first-page":"731","DOI":"10.5152\/tjg.2022.21855","volume":"33","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. Aspirin inhibits carcinogenesis of intestinal mucosal cells in UC mice through inhibiting IL-6\/JAK\/STAT3 signaling pathway and modulating apoptosis and proliferation. Turk. J. Gastroenterol. 33, 731\u2013742 (2022).","journal-title":"Turk. J. Gastroenterol."},{"key":"2345_CR312","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2022.115906","volume":"438","author":"MS El-Ghannam","year":"2022","unstructured":"El-Ghannam, M. S. et al. Linagliptin ameliorates acetic acid-induced colitis via modulating AMPK\/SIRT1\/PGC-1\u03b1 and JAK2\/STAT3 signaling pathway in rats. Toxicol. Appl. Pharm. 438, 115906 (2022).","journal-title":"Toxicol. Appl. Pharm."},{"key":"2345_CR313","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e14176","volume":"9","author":"K Xiong","year":"2023","unstructured":"Xiong, K. et al. Berberine promotes M2 macrophage polarisation through the IL-4-STAT6 signalling pathway in ulcerative colitis treatment. Heliyon 9, e14176 (2023).","journal-title":"Heliyon"},{"key":"2345_CR314","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/fsn3.3124","volume":"11","author":"F Wu","year":"2023","unstructured":"Wu, F. et al. Alleviative mechanism and effect of Bifidobacterium animalisA6 on dextran sodium sulfate-induced ulcerative colitis in mice. Food Sci. Nutr. 11, 892\u2013902 (2023).","journal-title":"Food Sci. Nutr."},{"key":"2345_CR315","doi-asserted-by":"crossref","unstructured":"Bridges, M. C., Daulagala, A. C. & Kourtidis, A. LNCcation: lncRNA localization and function. J Cell Biol. 220, e202009045 (2021).","DOI":"10.1083\/jcb.202009045"},{"key":"2345_CR316","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/cac2.12108","volume":"41","author":"YT Tan","year":"2021","unstructured":"Tan, Y. T. et al. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun.41, 109\u2013120 (2021).","journal-title":"Cancer Commun."},{"key":"2345_CR317","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.814","volume":"11","author":"H Wang","year":"2023","unstructured":"Wang, H. et al. Expression and significant roles of the lncRNA NEAT1\/miR-493-5p\/Rab27A axis in ulcerative colitis. Immun. Inflamm. Dis. 11, e814 (2023).","journal-title":"Immun. Inflamm. Dis."},{"key":"2345_CR318","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.2147\/IJGM.S304837","volume":"14","author":"J Rao","year":"2021","unstructured":"Rao, J. et al. LncRNA UCA1 accelerates the progression of ulcerative colitis via mediating the miR-331-3p\/BRD4 Axis. Int. J. Gen. Med. 14, 2427\u20132435 (2021).","journal-title":"Int. J. Gen. Med."},{"key":"2345_CR319","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s13577-020-00428-5","volume":"34","author":"Y Tian","year":"2021","unstructured":"Tian, Y. et al. LncRNA TUG1 regulates the balance of HuR and miR-29b-3p and inhibits intestinal epithelial cell apoptosis in a mouse model of ulcerative colitis. Hum. Cell 34, 37\u201348 (2021).","journal-title":"Hum. Cell"},{"key":"2345_CR320","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1080\/21655979.2021.1953219","volume":"12","author":"H Li","year":"2021","unstructured":"Li, H. et al. Long non-coding RNA SNHG5 regulates ulcerative colitis via microRNA-375 \/ Janus kinase-2 axis. Bioengineered 12, 4150\u20134158 (2021).","journal-title":"Bioengineered"},{"key":"2345_CR321","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1159\/000513330","volume":"39","author":"T Yu","year":"2021","unstructured":"Yu, T. et al. Long noncoding RNA PMS2L2 downregulates miR-24 through methylation to suppress cell apoptosis in ulcerative colitis. Dig. Dis. 39, 467\u2013476 (2021).","journal-title":"Dig. Dis."},{"key":"2345_CR322","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002263R","volume":"35","author":"M Ye","year":"2021","unstructured":"Ye, M. et al. An NF-\u03baB-responsive long noncoding RNA, PINT, regulates TNF-\u03b1 gene transcription by scaffolding p65 and EZH2. FASEB J. 35, e21667 (2021).","journal-title":"FASEB J."},{"key":"2345_CR323","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/ecco-jcc\/jjad006","volume":"17","author":"KE Sosnovski","year":"2023","unstructured":"Sosnovski, K. E. et al. GATA6-AS1 regulates intestinal epithelial mitochondrial functions, and its reduced expression is linked to intestinal inflammation and less favourable disease course in ulcerative colitis. J. Crohns Colitis 17, 960\u2013971 (2023).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR324","doi-asserted-by":"publisher","first-page":"8961","DOI":"10.1080\/21655979.2022.2037957","volume":"13","author":"S Ni","year":"2022","unstructured":"Ni, S., Liu, Y., Zhong, J. & Shen, Y. Inhibition of LncRNA-NEAT1 alleviates intestinal epithelial cells (IECs) dysfunction in ulcerative colitis by maintaining the homeostasis of the glucose metabolism through the miR-410-3p-LDHA axis. Bioengineered 13, 8961\u20138971 (2022).","journal-title":"Bioengineered"},{"key":"2345_CR325","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156338","volume":"170","author":"L Cao","year":"2023","unstructured":"Cao, L. et al. LncRNA MIR4435-2HG suppression regulates macrophage M1\/M2 polarization and reduces intestinal inflammation in mice with ulcerative colitis. Cytokine 170, 156338 (2023).","journal-title":"Cytokine"},{"key":"2345_CR326","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s10753-020-01400-z","volume":"44","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Long Non-coding RNA MEG3 alleviated ulcerative colitis through upregulating miR-98-5p-Sponged IL-10. Inflammation 44, 1049\u20131059 (2021).","journal-title":"Inflammation"},{"key":"2345_CR327","doi-asserted-by":"publisher","first-page":"12722","DOI":"10.1080\/21655979.2021.2010368","volume":"12","author":"YX Wang","year":"2021","unstructured":"Wang, Y. X. et al. Mechanism of M2 macrophage-derived extracellular vesicles carrying lncRNA MEG3 in inflammatory responses in ulcerative colitis. Bioengineered 12, 12722\u201312739 (2021).","journal-title":"Bioengineered"},{"key":"2345_CR328","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1631\/jzus.B2100793","volume":"23","author":"Y Xu","year":"2022","unstructured":"Xu, Y. et al. HucMSC-Ex alleviates inflammatory bowel disease via the lnc78583-mediated miR3202\/HOXB13 pathway. J. Zhejiang Univ. Sci. B 23, 423\u2013431 (2022).","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"2345_CR329","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1093\/bib\/bby054","volume":"20","author":"L Chen","year":"2019","unstructured":"Chen, L. et al. Trends in the development of miRNA bioinformatics tools. Brief. Bioinform. 20, 1836\u20131852 (2019).","journal-title":"Brief. Bioinform."},{"key":"2345_CR330","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","volume":"38","author":"C Diener","year":"2022","unstructured":"Diener, C., Keller, A. & Meese, E. Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet. 38, 613\u2013626 (2022).","journal-title":"Trends Genet."},{"key":"2345_CR331","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/SHK.0000000000002167","volume":"60","author":"Q An","year":"2023","unstructured":"An, Q. et al. CIRC_0085323 silencing inhibits TNF-\u0391-induced normal human colonic epithelial cell inflammation and apoptosis through the MIR-495-3P\/TRAF3 AXIS. Shock 60, 298\u2013305 (2023).","journal-title":"Shock"},{"key":"2345_CR332","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2240035","volume":"15","author":"S Wei","year":"2023","unstructured":"Wei, S. et al. Exosomal-miR-129-2-3p derived from Fusobacterium nucleatum-infected intestinal epithelial cells promotes experimental colitis through regulating TIMELESS-mediated cellular senescence pathway. Gut Microbes 15, 2240035 (2023).","journal-title":"Gut Microbes"},{"key":"2345_CR333","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1080\/13813455.2020.1762656","volume":"128","author":"M Naghdalipour","year":"2022","unstructured":"Naghdalipour, M. et al. Alteration of miR-21, miR-433 and miR-590 tissue expression related to the TGF-\u03b2 signaling pathway in ulcerative colitis patients. Arch. Physiol. Biochem. 128, 1170\u20131174 (2022).","journal-title":"Arch. Physiol. Biochem."},{"key":"2345_CR334","doi-asserted-by":"publisher","first-page":"e00560","DOI":"10.14309\/ctg.0000000000000560","volume":"14","author":"C Apolit","year":"2023","unstructured":"Apolit, C. et al. ABX464 (Obefazimod) Upregulates miR-124 to reduce proinflammatory markers in inflammatory bowel diseases. Clin. Transl. Gastroenterol. 14, e00560 (2023).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"2345_CR335","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10616-021-00490-3","volume":"73","author":"C Zheng","year":"2021","unstructured":"Zheng, C., Lu, T. & Fan, Z. miR-200b-3p alleviates TNF-\u03b1-induced apoptosis and inflammation of intestinal epithelial cells and ulcerative colitis progression in rats via negatively regulating KHDRBS1. Cytotechnology 73, 727\u2013743 (2021).","journal-title":"Cytotechnology"},{"key":"2345_CR336","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.4081\/ejh.2022.3316","volume":"66","author":"Y Lin","year":"2022","unstructured":"Lin, Y. et al. Effects of miR-939 and miR-376A on ulcerative colitis using a decoy strategy to inhibit NF-\u03baB and NFAT expression. Eur. J. Histochem. 66, 3316 (2022).","journal-title":"Eur. J. Histochem."},{"key":"2345_CR337","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119603","volume":"278","author":"P Wang","year":"2021","unstructured":"Wang, P. et al. Effect of MicroRNA145 on the multidrug resistance gene of ulcerative colitis in rats. Life Sci. 278, 119603 (2021).","journal-title":"Life Sci."},{"key":"2345_CR338","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3390\/cells9081909","volume":"9","author":"I Schoultz","year":"2020","unstructured":"Schoultz, I. & Keita, \u00c5V. The intestinal barrier and current techniques for the assessment of gut permeability. Cells 9, 1909 (2020).","journal-title":"Cells"},{"key":"2345_CR339","doi-asserted-by":"crossref","unstructured":"Do, H. J., Kim, Y. S. & Oh, T. W. Effect of Polycan, a \u03b2-Glucan from Aureobasidium pullulans SM-2001, on inflammatory response and intestinal barrier function in DSS-induced ulcerative colitis. Int. J. Mol. Sci. 24, 14773 (2023).","DOI":"10.3390\/ijms241914773"},{"key":"2345_CR340","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04463-4","volume":"13","author":"A Soroosh","year":"2021","unstructured":"Soroosh, A. et al. Loss of miR-24-3p promotes epithelial cell apoptosis and impairs the recovery from intestinal inflammation. Cell Death Dis. 13, 8 (2021).","journal-title":"Cell Death Dis."},{"key":"2345_CR341","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/fcp.12650","volume":"35","author":"H Zhang","year":"2021","unstructured":"Zhang, H., Zhang, F. & Li, W. Function of intestinal barrier protected by regulating the miR-199a-3p in ulcerative colitis: modulation of IL-23\/IL-17A axis. Fundam. Clin. Pharm. 35, 852\u2013860 (2021).","journal-title":"Fundam. Clin. Pharm."},{"key":"2345_CR342","doi-asserted-by":"publisher","first-page":"109957","DOI":"10.1016\/j.cellsig.2021.109957","volume":"82","author":"H Guo","year":"2021","unstructured":"Guo, H., Zhang, L., Wang, Y. & He, X. Mechanisms of HuR in regulation of epithelial cell apoptosis in rat ulcerative colitis. Cell Signal. 82, 109957 (2021).","journal-title":"Cell Signal."},{"key":"2345_CR343","doi-asserted-by":"crossref","unstructured":"Scalavino, V. et al. The increase of miR-195-5p reduces intestinal permeability in ulcerative colitis, modulating tight junctions\u2019 expression. Int. J. Mol. Sci. 23, 5840 (2022).","DOI":"10.3390\/ijms23105840"},{"key":"2345_CR344","doi-asserted-by":"crossref","unstructured":"Scalavino, V. et al. miR-195-5p regulates tight junctions expression via Claudin-2 downregulation in ulcerative colitis. Biomedicines. 10, 919 (2022).","DOI":"10.3390\/biomedicines10040919"},{"key":"2345_CR345","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/kjm2.12359","volume":"37","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. & Wang, S. F. miR-330 alleviates dextran sodium sulfate-induced ulcerative colitis through targeting IRAK1 in rats. Kaohsiung J. Med. Sci. 37, 497\u2013504 (2021).","journal-title":"Kaohsiung J. Med. Sci."},{"key":"2345_CR346","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.2147\/JIR.S302832","volume":"14","author":"J Guo","year":"2021","unstructured":"Guo, J., Zhang, R., Zhao, Y. & Wang, J. MiRNA-29c-3p promotes intestinal inflammation via targeting leukemia inhibitory factor in ulcerative colitis. J. Inflamm. Res. 14, 2031\u20132043 (2021).","journal-title":"J. Inflamm. Res."},{"key":"2345_CR347","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s10735-021-10021-1","volume":"52","author":"S Tang","year":"2021","unstructured":"Tang, S., Guo, W., Kang, L. & Liang, J. MiRNA-182-5p aggravates experimental ulcerative colitis via sponging Claudin-2. J. Mol. Histol. 52, 1215\u20131224 (2021).","journal-title":"J. Mol. Histol."},{"key":"2345_CR348","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.660614","volume":"8","author":"L Gu","year":"2021","unstructured":"Gu, L. et al. Exosomal MicroRNA-181a derived from mesenchymal stem cells improves gut microbiota composition, barrier function, and inflammatory status in an experimental colitis model. Front. Med. 8, 660614 (2021).","journal-title":"Front. Med."},{"key":"2345_CR349","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/ibd\/izac177","volume":"29","author":"S Wei","year":"2023","unstructured":"Wei, S. et al. Fusobacterium nucleatum extracellular vesicles promote experimental colitis by modulating autophagy via the miR-574-5p\/CARD3 Axis. Inflamm. Bowel Dis. 29, 9\u201326 (2023).","journal-title":"Inflamm. Bowel Dis."},{"key":"2345_CR350","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1053\/j.gastro.2021.08.003","volume":"161","author":"Y Cao","year":"2021","unstructured":"Cao, Y. et al. Enterotoxigenic bacteroidesfragilis promotes intestinal inflammation and malignancy by inhibiting exosome-packaged miR-149-3p. Gastroenterology 161, 1552\u20131566.e1512 (2021).","journal-title":"Gastroenterology"},{"key":"2345_CR351","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang, X., Stockwell, B. R. & Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Biol. 22, 266\u2013282 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2345_CR352","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202300379","volume":"62","author":"F Zeng","year":"2023","unstructured":"Zeng, F. et al. Ferroptosis detection: from approaches to applications. Angew. Chem. Int. Ed. Engl. 62, e202300379 (2023).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2345_CR353","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/ibd\/izad050","volume":"29","author":"L Deng","year":"2023","unstructured":"Deng, L. et al. Identification of Lipocalin 2 as a potential ferroptosis-related gene in ulcerative colitis. Inflamm. Bowel Dis. 29, 1446\u20131457 (2023).","journal-title":"Inflamm. Bowel Dis."},{"key":"2345_CR354","doi-asserted-by":"publisher","first-page":"300060521104297","DOI":"10.1177\/03000605211042975","volume":"49","author":"DJ Cui","year":"2021","unstructured":"Cui, D. J. et al. Integrative analysis of ferroptosis-related genes in ulcerative colitis. J. Int. Med. Res. 49, 3000605211042975 (2021).","journal-title":"J. Int. Med. Res."},{"key":"2345_CR355","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121312","volume":"314","author":"Y Wu","year":"2023","unstructured":"Wu, Y. et al. Deferasirox alleviates DSS-induced ulcerative colitis in mice by inhibiting ferroptosis and improving intestinal microbiota. Life Sci. 314, 121312 (2023).","journal-title":"Life Sci."},{"key":"2345_CR356","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.dld.2021.02.011","volume":"53","author":"S Dong","year":"2021","unstructured":"Dong, S. et al. Furin inhibits epithelial cell injury and alleviates experimental colitis by activating the Nrf2-Gpx4 signaling pathway. Dig. Liver Dis. 53, 1276\u20131285 (2021).","journal-title":"Dig. Liver Dis."},{"key":"2345_CR357","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1007\/s00535-023-02016-4","volume":"58","author":"A Yokote","year":"2023","unstructured":"Yokote, A. et al. Ferroptosis in the colon epithelial cells as a therapeutic target for ulcerative colitis. J. Gastroenterol. 58, 868\u2013882 (2023).","journal-title":"J. Gastroenterol."},{"key":"2345_CR358","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/1751-2980.13176","volume":"24","author":"SP Sun","year":"2023","unstructured":"Sun, S. P. et al. AMPK activation alleviated dextran sulfate sodium-induced colitis by inhibiting ferroptosis. J. Dig. Dis. 24, 213\u2013223 (2023).","journal-title":"J. Dig. Dis."},{"key":"2345_CR359","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.drudis.2020.09.029","volume":"25","author":"K Thangaraj","year":"2020","unstructured":"Thangaraj, K., Ponnusamy, L., Natarajan, S. R. & Manoharan, R. MELK\/MPK38 in cancer: from mechanistic aspects to therapeutic strategies. Drug Discov. Today 25, 2161\u20132173 (2020).","journal-title":"Drug Discov. Today"},{"key":"2345_CR360","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.freeradbiomed.2021.06.012","volume":"172","author":"B Tang","year":"2021","unstructured":"Tang, B. et al. Pharmacological inhibition of MELK restricts ferroptosis and the inflammatory response in colitis and colitis-propelled carcinogenesis. Free Radic. Biol. Med. 172, 312\u2013329 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"2345_CR361","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121272","volume":"313","author":"L Luo","year":"2023","unstructured":"Luo, L. et al. ACSF2-mediated ferroptosis is involved in ulcerative colitis. Life Sci. 313, 121272 (2023).","journal-title":"Life Sci."},{"key":"2345_CR362","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2022.109106","volume":"109","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. High-fat diet alleviates colitis by inhibiting ferroptosis via solute carrier family seven member 11. J. Nutr. Biochem. 109, 109106 (2022).","journal-title":"J. Nutr. Biochem."},{"key":"2345_CR363","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10, 417\u2013426 (2002).","journal-title":"Mol. Cell"},{"key":"2345_CR364","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou, R., Yazdi, A. S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221\u2013225 (2011).","journal-title":"Nature"},{"key":"2345_CR365","first-page":"625","volume":"48","author":"CQ Xie","year":"2023","unstructured":"Xie, C. Q. et al. Acupoint catgut embedding relieves colonic inflammatory injury by down-regulating NLRP3\/Caspase-1 signaling pathway in rats with ulcerative colitis. Zhen Ci Yan Jiu 48, 625\u2013634 (2023).","journal-title":"Zhen Ci Yan Jiu"},{"key":"2345_CR366","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.canlet.2021.10.002","volume":"523","author":"X Shao","year":"2021","unstructured":"Shao, X. et al. Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis. Cancer Lett. 523, 170\u2013181 (2021).","journal-title":"Cancer Lett."},{"key":"2345_CR367","doi-asserted-by":"publisher","first-page":"119154","DOI":"10.1016\/j.lfs.2021.119154","volume":"271","author":"MS Serrya","year":"2021","unstructured":"Serrya, M. S., El-Sheakh, A. R. & Makled, M. N. Evaluation of the therapeutic effects of mycophenolate mofetil targeting Nrf-2 and NLRP3 inflammasome in acetic acid induced ulcerative colitis in rats. Life Sci. 271, 119154 (2021).","journal-title":"Life Sci."},{"key":"2345_CR368","doi-asserted-by":"publisher","first-page":"11985","DOI":"10.1021\/acs.jmedchem.2c00523","volume":"65","author":"X Wu","year":"2022","unstructured":"Wu, X. et al. Discovery of a novel oral proteasome inhibitor to Block NLRP3 inflammasome activation with anti-inflammation activity. J. Med. Chem. 65, 11985\u201312001 (2022).","journal-title":"J. Med. Chem."},{"key":"2345_CR369","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1038\/s41401-021-00825-y","volume":"43","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation in macrophages. Acta Pharm. Sin. 43, 2042\u20132054 (2022).","journal-title":"Acta Pharm. Sin."},{"key":"2345_CR370","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111194","volume":"125","author":"P Wang","year":"2023","unstructured":"Wang, P. et al. The E3 ubiquitin ligase RNF31 mediates the development of ulcerative colitis by regulating NLRP3 inflammasome activation. Int. Immunopharmacol. 125, 111194 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"2345_CR371","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1007\/s00432-022-04029-7","volume":"148","author":"S Keane","year":"2022","unstructured":"Keane, S. et al. Inflammation suppresses DLG2 expression decreasing inflammasome formation. J. Cancer Res. Clin. Oncol. 148, 2295\u20132311 (2022).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"2345_CR372","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.145299","volume":"768","author":"F Zhang","year":"2021","unstructured":"Zhang, F. et al. Heat shock transcription factor 2 reduces the secretion of IL-1\u03b2 by inhibiting NLRP3 inflammasome activation in ulcerative colitis. Gene 768, 145299 (2021).","journal-title":"Gene"},{"key":"2345_CR373","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/s41401-023-01054-1","volume":"44","author":"HY Wang","year":"2023","unstructured":"Wang, H. Y. et al. Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases. Acta Pharm. Sin. 44, 1687\u20131700 (2023).","journal-title":"Acta Pharm. Sin."},{"key":"2345_CR374","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/cbin.11935","volume":"47","author":"S Yu","year":"2023","unstructured":"Yu, S., Qian, H., Zhang, D. & Jiang, Z. Ferulic acid relieved ulcerative colitis by inhibiting the TXNIP\/NLRP3 pathway in rats. Cell Biol. Int. 47, 417\u2013427 (2023).","journal-title":"Cell Biol. Int."},{"key":"2345_CR375","doi-asserted-by":"crossref","unstructured":"Saber, S. et al. A novel combination therapy using Rosuvastatin and lactobacillus combats dextran sodium sulfate-induced colitis in high-fat diet-fed rats by targeting the TXNIP\/NLRP3 interaction and influencing gut microbiome composition. Pharmaceuticals. 14, 341 (2021).","DOI":"10.3390\/ph14040341"},{"key":"2345_CR376","doi-asserted-by":"publisher","first-page":"108174","DOI":"10.1016\/j.intimp.2021.108174","volume":"101","author":"HM Hafez","year":"2021","unstructured":"Hafez, H. M. et al. Protective effect of mirtazapine against acetic acid-induced ulcerative colitis in rats: role of NLRP3 inflammasome pathway. Int. Immunopharmacol. 101, 108174 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"2345_CR377","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1205323","volume":"14","author":"X Sun","year":"2023","unstructured":"Sun, X. et al. Bacteroides dorei BDX-01 alleviates DSS-induced experimental colitis in mice by regulating intestinal bile salt hydrolase activity and the FXR-NLRP3 signaling pathway. Front. Pharm. 14, 1205323 (2023).","journal-title":"Front. Pharm."},{"key":"2345_CR378","doi-asserted-by":"crossref","unstructured":"Wen, C. et al. Dietary zinc ameliorates TNBS-induced colitis in mice associated with regulation of Th1\/Th2\/Th17 balance and NF-\u03baB\/NLRP3 signaling pathway. Biol. Trace Elem Res. 202, 659\u2013670 (2023).","DOI":"10.1007\/s12011-023-03715-y"},{"key":"2345_CR379","doi-asserted-by":"publisher","first-page":"9597","DOI":"10.1021\/acs.jafc.1c03792","volume":"69","author":"N He","year":"2021","unstructured":"He, N. et al. Preventive and prebiotic effect of \u03b1-Galacto-Oligosaccharide against dextran sodium sulfate-induced colitis and gut microbiota dysbiosis in mice. J. Agric. Food Chem. 69, 9597\u20139607 (2021).","journal-title":"J. Agric. Food Chem."},{"key":"2345_CR380","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153511","volume":"224","author":"T Wang","year":"2021","unstructured":"Wang, T. et al. Mist1 promoted inflammation in colitis model via K+-ATPase NLRP3 inflammasome by SNAI1. Pathol. Res. Pract. 224, 153511 (2021).","journal-title":"Pathol. Res. Pract."},{"key":"2345_CR381","doi-asserted-by":"crossref","unstructured":"Abdel-Razek, E. A., Mahmoud, H. M. & Azouz, A. A. Management of ulcerative colitis by dichloroacetate: impact on NFATC1\/NLRP3\/IL1B signaling based on bioinformatics analysis combined with in vivo experimental verification. Inflammopharmacology 32, 667\u2013682 (2023).","DOI":"10.1007\/s10787-023-01362-2"},{"key":"2345_CR382","doi-asserted-by":"crossref","unstructured":"Ikeda, Y. & Matsuda, S. Gut protective effect from D-Methionine or butyric acid against DSS and carrageenan-induced ulcerative colitis. Molecules. 28, 4392 (2023).","DOI":"10.3390\/molecules28114392"},{"key":"2345_CR383","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102453","volume":"111","author":"AM Gorabi","year":"2020","unstructured":"Gorabi, A. M. et al. The pivotal role of CD69 in autoimmunity. J. Autoimmun. 111, 102453 (2020).","journal-title":"J. Autoimmun."},{"key":"2345_CR384","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1177\/0148607116638493","volume":"41","author":"CH Huang","year":"2017","unstructured":"Huang, C. H. et al. Dietary \u03c9-6\/\u03c9-3 polyunsaturated fatty acid ratios affect the homeostasis of Th\/Treg cells in mice with dextran sulfate sodium-induced colitis. JPEN J. Parenter. Enter. Nutr. 41, 647\u2013656 (2017).","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"2345_CR385","doi-asserted-by":"crossref","unstructured":"Yan, S. C. et al. Dihydroartemisinin regulates the Th\/Treg balance by inducing activated CD4+ T cell apoptosis via heme Oxygenase-1 induction in mouse models of inflammatory bowel disease. Molecules. 24, 2475 (2019).","DOI":"10.3390\/molecules24132475"},{"key":"2345_CR386","doi-asserted-by":"publisher","first-page":"5226","DOI":"10.3748\/wjg.v29.i36.5226","volume":"29","author":"LX Zheng","year":"2023","unstructured":"Zheng, L. X. et al. Curcumin alleviated dextran sulfate sodium-induced colitis by recovering memory Th\/Tfh subset balance. World J. Gastroenterol. 29, 5226\u20135239 (2023).","journal-title":"World J. Gastroenterol."},{"key":"2345_CR387","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/ibd\/izab312","volume":"28","author":"G Dong","year":"2022","unstructured":"Dong, G. et al. Protein Kinase CK2 maintains reciprocal balance between Th17 and Treg cells in the pathogenesis of UC. Inflamm. Bowel Dis. 28, 830\u2013842 (2022).","journal-title":"Inflamm. Bowel Dis."},{"key":"2345_CR388","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s10529-022-03307-1","volume":"44","author":"F Gao","year":"2022","unstructured":"Gao, F. et al. BMSCs improve TNBS-induced colitis in rats by inducing Treg differentiation by expressing PD-L1. Biotechnol. Lett. 44, 1263\u20131275 (2022).","journal-title":"Biotechnol. Lett."},{"key":"2345_CR389","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111130","volume":"125","author":"Q Fan","year":"2023","unstructured":"Fan, Q. et al. Inhibition of \u03b12,6-sialyltransferase relieves symptoms of ulcerative colitis by regulating Th17 cells polarization. Int. Immunopharmacol. 125, 111130 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"2345_CR390","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102017","volume":"298","author":"JJ Wang","year":"2022","unstructured":"Wang, J. J. et al. The JMJD3 histone demethylase inhibitor GSK-J1 ameliorates lipopolysaccharide-induced inflammation in a mastitis model. J. Biol. Chem. 298, 102017 (2022).","journal-title":"J. Biol. Chem."},{"key":"2345_CR391","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109000","volume":"110","author":"XY Leng","year":"2022","unstructured":"Leng, X. Y. et al. JMJD3\/H3K27me3 epigenetic modification regulates Th17\/Treg cell differentiation in ulcerative colitis. Int. Immunopharmacol. 110, 109000 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"2345_CR392","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02943-x","volume":"19","author":"J Huang","year":"2021","unstructured":"Huang, J. et al. Lactobacillus paracasei R3 protects against dextran sulfate sodium (DSS)-induced colitis in mice via regulating Th17\/Treg cell balance. J. Transl. Med. 19, 356 (2021).","journal-title":"J. Transl. Med."},{"key":"2345_CR393","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.643215","volume":"12","author":"MN Rana","year":"2021","unstructured":"Rana, M. N. et al. PDE9 inhibitor PF-04447943 attenuates DSS-Induced colitis by suppressing oxidative stress, inflammation, and regulating T-Cell Polarization. Front. Pharm. 12, 643215 (2021).","journal-title":"Front. Pharm."},{"key":"2345_CR394","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46365-x","volume":"15","author":"C Liu","year":"2024","unstructured":"Liu, C. et al. Targeting P2Y(14)R protects against necroptosis of intestinal epithelial cells through PKA\/CREB\/RIPK1 axis in ulcerative colitis. Nat. Commun. 15, 2083 (2024).","journal-title":"Nat. Commun."},{"key":"2345_CR395","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1021\/acs.jmedchem.3c00210","volume":"66","author":"Y Zhu","year":"2023","unstructured":"Zhu, Y. et al. Discovery of selective P2Y(6)R antagonists with high affinity and in vivo efficacy for inflammatory disease therapy. J. Med. Chem. 66, 6315\u20136332 (2023).","journal-title":"J. Med. Chem."},{"key":"2345_CR396","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111238","volume":"126","author":"X Cui","year":"2024","unstructured":"Cui, X. et al. Therapeutic potential of a synthetic dual JAK1\/TYK2 inhibitor in inflammatory bowel disease. Int. Immunopharmacol. 126, 111238 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"2345_CR397","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1021\/acs.jmedchem.1c01137","volume":"65","author":"T Yang","year":"2022","unstructured":"Yang, T. et al. Identification of a Novel 2,8-Diazaspiro[4.5]decan-1-one derivative as a potent and selective dual TYK2\/JAK1 inhibitor for the treatment of inflammatory bowel disease. J. Med. Chem. 65, 3151\u20133172 (2022).","journal-title":"J. Med. Chem."},{"key":"2345_CR398","doi-asserted-by":"publisher","first-page":"148","DOI":"10.5217\/ir.2021.00168","volume":"21","author":"SY Shin","year":"2023","unstructured":"Shin, S. Y. et al. Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease. Intest Res. 21, 148\u2013160 (2023).","journal-title":"Intest Res."},{"key":"2345_CR399","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1197922","volume":"14","author":"H Zhao","year":"2023","unstructured":"Zhao, H. et al. Arecoline aggravates acute ulcerative colitis in mice by affecting intestinal microbiota and serum metabolites. Front. Immunol. 14, 1197922 (2023).","journal-title":"Front. Immunol."},{"key":"2345_CR400","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s42003-023-05023-6","volume":"6","author":"S Mondal","year":"2023","unstructured":"Mondal, S. et al. Chitosan functionalized Mn(3)O(4) nanoparticles counteracts ulcerative colitis in mice through modulation of cellular redox state. Commun. Biol. 6, 647 (2023).","journal-title":"Commun. Biol."},{"key":"2345_CR401","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.dld.2022.08.039","volume":"55","author":"N Dai","year":"2023","unstructured":"Dai, N., Haidar, O., Askari, A. & Segal, J. P. Colectomy rates in ulcerative colitis: a systematic review and meta-analysis. Dig. Liver Dis. 55, 13\u201320 (2023).","journal-title":"Dig. Liver Dis."},{"key":"2345_CR402","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10103-023-03932-w","volume":"38","author":"K Bitencourt","year":"2023","unstructured":"Bitencourt, K. et al. Effects of photobiomodulation in the experimental acetic acid-induced colitis: comparison between male and female. Lasers Med. Sci. 38, 271 (2023).","journal-title":"Lasers Med. Sci."},{"key":"2345_CR403","doi-asserted-by":"publisher","first-page":"1066252","DOI":"10.3389\/fnut.2022.1066252","volume":"9","author":"Y Hou","year":"2022","unstructured":"Hou, Y., Wang, S. F., Zhou, K. & Dai, S. X. Comparison and recommendation of dietary patterns based on nutrients for Eastern and Western patients with inflammatory bowel disease. Front. Nutr. 9, 1066252 (2022).","journal-title":"Front. Nutr."},{"key":"2345_CR404","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cgh.2020.02.047","volume":"19","author":"CH Lo","year":"2021","unstructured":"Lo, C. H. et al. Healthy lifestyle is associated with reduced mortality in patients with inflammatory bowel diseases. Clin. Gastroenterol. Hepatol. 19, 87\u201395.e84 (2021).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2345_CR405","doi-asserted-by":"publisher","first-page":"511","DOI":"10.14309\/ajg.0000000000002180","volume":"118","author":"Y Sun","year":"2023","unstructured":"Sun, Y. et al. The contribution of genetic risk and lifestyle factors in the development of adult-onset inflammatory bowel disease: a prospective cohort study. Am. J. Gastroenterol. 118, 511\u2013522 (2023).","journal-title":"Am. J. Gastroenterol."},{"key":"2345_CR406","doi-asserted-by":"crossref","unstructured":"Wu, J. et al. Intermittent fasting alleviates risk markers in a murine model of ulcerative colitis by modulating the gut microbiome and metabolome. Nutrients. 14, 5311 (2022).","DOI":"10.3390\/nu14245311"},{"key":"2345_CR407","doi-asserted-by":"crossref","unstructured":"Herrador-L\u00f3pez, M., Mart\u00edn-Masot, R. & Navas-L\u00f3pez, V. M. Dietary interventions in ulcerative colitis: a systematic review of the evidence with meta-analysis. Nutrients. 15, 4194 (2023).","DOI":"10.3390\/nu15194194"},{"key":"2345_CR408","doi-asserted-by":"publisher","first-page":"172","DOI":"10.34172\/aim.2023.26","volume":"26","author":"H Wei","year":"2023","unstructured":"Wei, H. et al. Body composition in inflammatory bowel disease. Arch. Iran. Med. 26, 172\u2013175 (2023).","journal-title":"Arch. Iran. Med."},{"key":"2345_CR409","doi-asserted-by":"publisher","first-page":"9309","DOI":"10.1039\/D3FO02885B","volume":"14","author":"Y Wen","year":"2023","unstructured":"Wen, Y. et al. Egg yolk phosphatidylcholine alleviates DSS-induced colitis in BALB\/c mice. Food Funct. 14, 9309\u20139323 (2023).","journal-title":"Food Funct."},{"key":"2345_CR410","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/fsn3.1914","volume":"9","author":"S Ma","year":"2021","unstructured":"Ma, S. et al. Protein diets with the role of immune and gut microbial regulation alleviate DSS-induced chronic ulcerative colitis. Food Sci. Nutr. 9, 1259\u20131270 (2021).","journal-title":"Food Sci. Nutr."},{"key":"2345_CR411","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1021\/acs.jafc.2c07437","volume":"71","author":"Y Guo","year":"2023","unstructured":"Guo, Y. et al. Effects of medium- and long-chain structured triacylglycerol on the therapeutic efficacy of vitamin D on ulcerative colitis: a consideration for efficient lipid delivery systems. J. Agric. Food Chem. 71, 4101\u20134112 (2023).","journal-title":"J. Agric. Food Chem."},{"key":"2345_CR412","doi-asserted-by":"crossref","unstructured":"Wang, Z. et al. Vitamin D receptor regulates methyltransferase like 14 to mitigate colitis-associated colorectal cancer. J. Genet. Genom. (2025).","DOI":"10.1016\/j.jgg.2024.12.020"},{"key":"2345_CR413","doi-asserted-by":"crossref","unstructured":"Kim, K. Y. et al. Fermented glutinous rice extract mitigates dss-induced ulcerative colitis by alleviating intestinal barrier function and improving gut microbiota and inflammation. Antioxidants. 12, 236 (2023).","DOI":"10.3390\/antiox12020336"},{"key":"2345_CR414","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.3390\/foods12101928","volume":"12","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. Fermented sargassum fusiforme mitigates ulcerative colitis in mice by regulating the intestinal barrier, oxidative stress, and the NF-\u03baB pathway. Foods 12, 1928 (2023).","journal-title":"Foods"},{"key":"2345_CR415","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3904\/kjim.2021.458","volume":"37","author":"SK Park","year":"2022","unstructured":"Park, S. K. et al. Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis. Korean J. Intern. Med. 37, 949\u2013957 (2022).","journal-title":"Korean J. Intern. Med."},{"key":"2345_CR416","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121699","volume":"324","author":"Y Ni","year":"2023","unstructured":"Ni, Y. et al. Bifidobacterium and Lactobacillus improve inflammatory bowel disease in zebrafish of different ages by regulating the intestinal mucosal barrier and microbiota. Life Sci. 324, 121699 (2023).","journal-title":"Life Sci."},{"key":"2345_CR417","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e12707","volume":"9","author":"K Nascimento da Silva","year":"2023","unstructured":"Nascimento da Silva, K. et al. Effects of kefir fermented milk beverage on sodium dextran sulfate (DSS)-induced colitis in rats. Heliyon 9, e12707 (2023).","journal-title":"Heliyon"},{"key":"2345_CR418","doi-asserted-by":"publisher","first-page":"8570","DOI":"10.7150\/thno.62046","volume":"11","author":"L Tong","year":"2021","unstructured":"Tong, L. et al. Milk-derived extracellular vesicles alleviate ulcerative colitis by regulating the gut immunity and reshaping the gut microbiota. Theranostics 11, 8570\u20138586 (2021).","journal-title":"Theranostics"},{"key":"2345_CR419","first-page":"300","volume":"36","author":"O Koohi","year":"2023","unstructured":"Koohi, O. et al. Evaluation of oral and topical bovine colostrum compared to mesalamine in the treatment of animal model of acetic acid-induced ulcerative colitis. Ann. Gastroenterol. 36, 300\u2013306 (2023).","journal-title":"Ann. Gastroenterol."},{"key":"2345_CR420","doi-asserted-by":"publisher","first-page":"8420","DOI":"10.1039\/D3FO00641G","volume":"14","author":"H Han","year":"2023","unstructured":"Han, H. et al. Incidental nanoparticles in black tea alleviate DSS-induced ulcerative colitis in BALB\/c mice. Food Funct. 14, 8420\u20138430 (2023).","journal-title":"Food Funct."},{"key":"2345_CR421","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.7150\/ijms.85521","volume":"20","author":"MH Wu","year":"2023","unstructured":"Wu, M. H. et al. The adverse and beneficial effects of polyphenols in green and black teas in vitro and in vivo. Int. J. Med. Sci. 20, 1247\u20131255 (2023).","journal-title":"Int. J. Med. Sci."},{"key":"2345_CR422","doi-asserted-by":"publisher","first-page":"117863881983452","DOI":"10.1177\/1178638819834526","volume":"12","author":"J Stavsky","year":"2019","unstructured":"Stavsky, J. & Maitra, R. The synergistic role of diet and exercise in the prevention, pathogenesis, and management of ulcerative colitis: an underlying metabolic mechanism. Nutr. Metab. Insights 12, 1178638819834526 (2019).","journal-title":"Nutr. Metab. Insights"},{"key":"2345_CR423","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4103\/ijpvm.ijpvm_162_22","volume":"14","author":"Z Kolahi","year":"2023","unstructured":"Kolahi, Z., Yaghoubi, A., Rezaeian, N. & Khazaei, M. Exercise improves clinical symptoms, pathological changes and oxidative\/antioxidative balance in animal model of colitis. Int. J. Prev. Med. 14, 46 (2023).","journal-title":"Int. J. Prev. Med."},{"key":"2345_CR424","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.14309\/ajg.0000000000002263","volume":"118","author":"D Ahuja","year":"2023","unstructured":"Ahuja, D. et al. Comparative speed of early symptomatic remission with advanced therapies for moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis. Am. J. Gastroenterol. 118, 1618\u20131625 (2023).","journal-title":"Am. J. Gastroenterol."},{"key":"2345_CR425","volume":"5","author":"A Awad","year":"2023","unstructured":"Awad, A. et al. 3D printed infliximab suppositories for rectal biologic delivery. Int. J. Pharm. X 5, 100176 (2023).","journal-title":"Int. J. Pharm. X"},{"key":"2345_CR426","first-page":"181","volume":"15","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. Chinese herbal medicines for treating ulcerative colitis via regulating gut microbiota-intestinal immunity axis. Chin. Herb. Med. 15, 181\u2013200 (2023).","journal-title":"Chin. Herb. Med."},{"key":"2345_CR427","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.106870","volume":"159","author":"X Hu","year":"2023","unstructured":"Hu, X. et al. Comparison of the molecular mechanisms of Fuzi Lizhong Pill and Huangqin decoction in the treatment of the cold and heat syndromes of ulcerative colitis based on network pharmacology. Comput Biol. Med. 159, 106870 (2023).","journal-title":"Comput Biol. Med."},{"key":"2345_CR428","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115902","volume":"303","author":"YY Li","year":"2023","unstructured":"Li, Y. Y. et al. Compatibility between cold-natured medicine CP and hot-natured medicine AZ synergistically mitigates colitis mice through attenuating inflammation and restoring gut barrier. J. Ethnopharmacol. 303, 115902 (2023).","journal-title":"J. Ethnopharmacol."},{"key":"2345_CR429","doi-asserted-by":"publisher","DOI":"10.1177\/15593258231155787","volume":"21","author":"EE Shibrya","year":"2023","unstructured":"Shibrya, E. E. et al. Apigenin and exposure to low dose Gamma radiation ameliorate acetic acid-induced ulcerative colitis in rats. Dose Response 21, 15593258231155787 (2023).","journal-title":"Dose Response"},{"key":"2345_CR430","doi-asserted-by":"publisher","DOI":"10.1590\/acb382923","volume":"38","author":"ZY Yu","year":"2023","unstructured":"Yu, Z. Y., Xu, Y. S., Tang, M. & Xin, W. F. The effect of olsalazine of chinese generic drugs on ulcerative colitis induced by dextran sulfate sodium salt in BALB\/c mice. Acta Cir. Bras. 38, e382923 (2023).","journal-title":"Acta Cir. Bras."},{"key":"2345_CR431","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122981","volume":"640","author":"HS Sardou","year":"2023","unstructured":"Sardou, H. S. et al. Comparison of 5-ASA layered or matrix pellets coated with a combination of ethylcellulose and eudragits L and s in the treatment of ulcerative colitis in rats. Int. J. Pharm. 640, 122981 (2023).","journal-title":"Int. J. Pharm."},{"key":"2345_CR432","first-page":"Cd013743","volume":"5","author":"M Gordon","year":"2022","unstructured":"Gordon, M., Sinopoulou, V., Grafton-Clarke, C. & Akobeng, A. K. Antibiotics for the induction and maintenance of remission in ulcerative colitis. Cochrane Database Syst. Rev. 5, Cd013743 (2022).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2345_CR433","doi-asserted-by":"publisher","first-page":"9554","DOI":"10.3390\/ijms24119554","volume":"24","author":"A Blais","year":"2023","unstructured":"Blais, A. et al. Efficiency of Orexin-A for inflammatory flare and mucosal healing in experimental colitis: comparison with the Anti-TNF Alpha Infliximab. Int J. Mol. Sci. 24, 9554 (2023).","journal-title":"Int J. Mol. Sci."},{"key":"2345_CR434","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106935","volume":"196","author":"F Penagini","year":"2023","unstructured":"Penagini, F. et al. Dual biological therapy and small molecules in pediatric inflammatory bowel disease. Pharm. Res. 196, 106935 (2023).","journal-title":"Pharm. Res."},{"key":"2345_CR435","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1111\/apt.17387","volume":"57","author":"S Ikegami","year":"2023","unstructured":"Ikegami, S. et al. Efficacy of 1-kestose supplementation in patients with mild to moderate ulcerative colitis: a randomised, double-blind, placebo-controlled pilot study. Aliment Pharm. Ther. 57, 1249\u20131257 (2023).","journal-title":"Aliment Pharm. Ther."},{"key":"2345_CR436","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156633","volume":"140","author":"Q Wei","year":"2025","unstructured":"Wei, Q. et al. Quercetin protected the gut barrier in ulcerative colitis by activating aryl hydrocarbon receptor. Phytomedicine 140, 156633 (2025).","journal-title":"Phytomedicine"},{"key":"2345_CR437","doi-asserted-by":"crossref","unstructured":"Chen, Z. et al. Anti-Inflammatory Effects of Two-Week Sacral Nerve Stimulation Therapy in Patients With Ulcerative Colitis. Neuromodulation 27, 360\u2013371 (2023).","DOI":"10.1016\/j.neurom.2023.01.019"},{"key":"2345_CR438","first-page":"818","volume":"48","author":"RL Wu","year":"2023","unstructured":"Wu, R. L. et al. [Effect of electroacupuncture on colonic autophagy and AMPK\/mTOR signaling pathway in rats with acute ulcerative colitis]. Zhen Ci Yan Jiu 48, 818\u2013824 (2023).","journal-title":"Zhen Ci Yan Jiu"},{"key":"2345_CR439","first-page":"158","volume":"48","author":"Q Huang","year":"2023","unstructured":"Huang, Q. et al. [Effect of electroacupuncture on Notch\/NF-\u03baB signaling pathway in colonic mucosa of mice with ulcerative colitis]. Zhen C. i Yan Jiu 48, 158\u2013164 (2023).","journal-title":"i Yan Jiu"},{"key":"2345_CR440","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/jama.2023.15389","volume":"330","author":"B Gros","year":"2023","unstructured":"Gros, B. & Kaplan, G. G. Ulcerative colitis in adults: a review. JAMA 330, 951\u2013965 (2023).","journal-title":"JAMA"},{"key":"2345_CR441","doi-asserted-by":"crossref","unstructured":"Nalinbenjapun, S. et al. Synthesis and characterization of 5-aminosalicylic acid-azobenzyl-chitosan conjugates-based prodrugs for the colon targeted delivery in dextran sodium sulfate (DSS)-induced ulcerative colitis. Int. J. Biol. Macromol. 318, 144734 (2025).","DOI":"10.1016\/j.ijbiomac.2025.144734"},{"key":"2345_CR442","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/bcp.14479","volume":"87","author":"N Vande Casteele","year":"2021","unstructured":"Vande Casteele, N., Jakate, A., McNamee, B. & Sandborn, W. J. Similar pharmacokinetics of three dosing regimens comprising two oral delayed-release mesalamine formulations in healthy adult volunteers: Randomised, open-label, parallel-group study. Br. J. Clin. Pharm. 87, 1141\u20131149 (2021).","journal-title":"Br. J. Clin. Pharm."},{"key":"2345_CR443","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cgh.2020.11.040","volume":"20","author":"C Ma","year":"2022","unstructured":"Ma, C. et al. Modeling endoscopic improvement after induction treatment with mesalamine in patients with mild-to-moderate ulcerative colitis. Clin. Gastroenterol. Hepatol. 20, 447\u2013454.e441 (2022).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2345_CR444","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.25122\/jml-2023-0194","volume":"16","author":"FR Jaafar","year":"2023","unstructured":"Jaafar, F. R. & Abu-Raghif, A. Comparative treatment of Sulfasalazine+Ezetimibe combination and Sulfasalazine in a rat model with induced colitis. J. Med. Life 16, 1165\u20131169 (2023).","journal-title":"J. Med. Life"},{"key":"2345_CR445","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s11033-024-10008-7","volume":"51","author":"M Moshiri","year":"2024","unstructured":"Moshiri, M. et al. Evaluation of the immunomodulatory activity of probiotics mixture and sulfasalazine against acetic acid-induced colitis in a murine model. Mol. Biol. Rep. 51, 1059 (2024).","journal-title":"Mol. Biol. Rep."},{"key":"2345_CR446","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s10620-008-0481-x","volume":"54","author":"S Nikfar","year":"2009","unstructured":"Nikfar, S., Rahimi, R., Rezaie, A. & Abdollahi, M. A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis. Dig. Dis. Sci. 54, 1157\u20131170 (2009).","journal-title":"Dig. Dis. Sci."},{"key":"2345_CR447","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.gastrohep.2012.08.005","volume":"36","author":"J Mart\u00ednez Gonz\u00e1lez","year":"2013","unstructured":"Mart\u00ednez Gonz\u00e1lez, J. et al. Rescue therapy with sulfasalazine prior to immunosuppressive or biological agents in ulcerative colitis poorly controlled with mesalazine]. Gastroenterol. Hepatol. 36, 7\u201310 (2013).","journal-title":"Gastroenterol. Hepatol."},{"key":"2345_CR448","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.3748\/wjg.v11.i16.2462","volume":"11","author":"QK Chen","year":"2005","unstructured":"Chen, Q. K. et al. Characteristics and therapeutic efficacy of sulfasalazine in patients with mildly and moderately active ulcerative colitis. World J. Gastroenterol. 11, 2462\u20132466 (2005).","journal-title":"World J. Gastroenterol."},{"key":"2345_CR449","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5009\/gnl220017","volume":"17","author":"H Nakase","year":"2023","unstructured":"Nakase, H. Acute severe ulcerative colitis: optimal strategies for drug therapy. Gut Liver 17, 49\u201357 (2023).","journal-title":"Gut Liver"},{"key":"2345_CR450","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1016\/j.clinthera.2017.09.011","volume":"39","author":"JB Rice","year":"2017","unstructured":"Rice, J. B. et al. Long-term systemic corticosteroid exposure: a systematic literature review. Clin. Ther. 39, 2216\u20132229 (2017).","journal-title":"Clin. Ther."},{"key":"2345_CR451","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/03639045.2023.2212789","volume":"49","author":"D Yang","year":"2023","unstructured":"Yang, D. et al. Budesonide-liposomes inclusion complex in thermosensitive gel alleviates DSS-induced ulcerative colitis in mice. Drug Dev. Ind. Pharm. 49, 341\u2013347 (2023).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"2345_CR452","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1021\/acs.molpharmaceut.2c00558","volume":"20","author":"RK Mishra","year":"2023","unstructured":"Mishra, R. K. et al. Caffeic acid-conjugated budesonide-loaded nanomicelle attenuates inflammation in experimental colitis. Mol. Pharm. 20, 172\u2013182 (2023).","journal-title":"Mol. Pharm."},{"key":"2345_CR453","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/ecco-jcc\/jjx032","volume":"11","author":"DT Rubin","year":"2017","unstructured":"Rubin, D. T. et al. Budesonide multimatrix is efficacious for mesalamine-refractory, mild to moderate ulcerative colitis: a Randomised, Placebo-controlled Trial. J. Crohns Colitis 11, 785\u2013791 (2017).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR454","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1111\/jgh.16692","volume":"39","author":"K Watanabe","year":"2024","unstructured":"Watanabe, K. et al. Impact of twice-daily budesonide foam administration on early clinical response and endoscopic remission in patients with ulcerative colitis: a post hoc analysis. J. Gastroenterol. Hepatol. 39, 2367\u20132376 (2024).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2345_CR455","doi-asserted-by":"publisher","first-page":"109348","DOI":"10.1016\/j.steroids.2023.109348","volume":"202","author":"BJ Harvey","year":"2024","unstructured":"Harvey, B. J. Molecular mechanisms of dexamethasone actions in COVID-19: Ion channels and airway surface liquid dynamics. Steroids 202, 109348 (2024).","journal-title":"Steroids"},{"key":"2345_CR456","first-page":"1872","volume":"19","author":"F Bossa","year":"2013","unstructured":"Bossa, F. et al. Erythrocytes-mediated delivery of dexamethasone 21-phosphate in steroid-dependent ulcerative colitis: a randomized, double-blind Sham-controlled study. Inflamm. Bowel Dis. 19, 1872\u20131879 (2013).","journal-title":"Inflamm. Bowel Dis."},{"key":"2345_CR457","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17213","volume":"12","author":"Q Li","year":"2024","unstructured":"Li, Q. et al. Bioinformatics analysis of oxidative stress genes in the pathogenesis of ulcerative colitis based on a competing endogenous RNA regulatory network. PeerJ 12, e17213 (2024).","journal-title":"PeerJ"},{"key":"2345_CR458","doi-asserted-by":"publisher","first-page":"113948","DOI":"10.1016\/j.addr.2021.113948","volume":"177","author":"S Subramaniam","year":"2021","unstructured":"Subramaniam, S., Joyce, P., Thomas, N. & Prestidge, C. A. Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections. Adv. Drug Deliv. Rev. 177, 113948 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2345_CR459","doi-asserted-by":"crossref","unstructured":"Pesole, P. L. et al. 90K\/Mac-2 BP is a new predictive biomarker of response to infliximab therapy in IBD patients. Int. J. Mol. Sci. 24, 3955 (2023).","DOI":"10.3390\/ijms24043955"},{"key":"2345_CR460","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10620-022-07472-1","volume":"68","author":"RS Dalal","year":"2023","unstructured":"Dalal, R. S., McClure, E. L., Marcus, J. & Allegretti, J. R. Comparative long-term drug survival of Vedolizumab, Adalimumab, and Infliximab in biologic-Na\u00efve patients with ulcerative Colitis. Dig. Dis. Sci. 68, 223\u2013232 (2023).","journal-title":"Dig. Dis. Sci."},{"key":"2345_CR461","doi-asserted-by":"crossref","unstructured":"Dignass, A. et al. Clinical profiles and outcomes in patients with inflammatory bowel disease receiving standard and escalated doses of targeted therapies: findings from a global real-world study. Curr. Med. Res. Opin, 39, 1695\u20131705 (2023).","DOI":"10.1080\/03007995.2023.2278695"},{"key":"2345_CR462","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122962","volume":"639","author":"Q Sun","year":"2023","unstructured":"Sun, Q. et al. Bio-adhesive and ROS-scavenging hydrogel microspheres for targeted ulcerative colitis therapy. Int. J. Pharm. 639, 122962 (2023).","journal-title":"Int. J. Pharm."},{"key":"2345_CR463","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/apt.17248","volume":"57","author":"T Straatmijer","year":"2023","unstructured":"Straatmijer, T. et al. Effectiveness and safety of tofacitinib for ulcerative colitis: two-year results of the ICC Registry. Aliment Pharm. Ther. 57, 117\u2013126 (2023).","journal-title":"Aliment Pharm. Ther."},{"key":"2345_CR464","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1177\/0897190020953019","volume":"34","author":"BN Palasik","year":"2021","unstructured":"Palasik, B. N. & Wang, H. Tofacitinib, the first oral janus kinase inhibitor approved for adult ulcerative colitis. J. Pharm. Pract. 34, 913\u2013921 (2021).","journal-title":"J. Pharm. Pract."},{"key":"2345_CR465","doi-asserted-by":"crossref","unstructured":"Dalal, R. S. et al. 1-Year comparative effectiveness of tofacitinib vs ustekinumab for patients with ulcerative colitis and prior antitumor necrosis factor failure. Inflamm Bowel Dis. 30, 395\u2013401 (2023).","DOI":"10.1093\/ibd\/izad087"},{"key":"2345_CR466","doi-asserted-by":"crossref","unstructured":"Dalal, R. S. et al. Clinical and endoscopic outcomes through 78 Weeks of tofacitinib therapy for ulcerative colitis in a US Cohort. Inflamm. Bowel Dis. 30, 1707\u20131713 (2023).","DOI":"10.1093\/ibd\/izad242"},{"key":"2345_CR467","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1093\/ibd\/izaa193","volume":"27","author":"MC Dubinsky","year":"2021","unstructured":"Dubinsky, M. C. et al. Tofacitinib in Patients With Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items In Phase 3 Randomized Controlled Induction Studies. Inflamm. Bowel Dis. 27, 983\u2013993 (2021).","journal-title":"Inflamm. Bowel Dis."},{"key":"2345_CR468","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1606910","volume":"376","author":"WJ Sandborn","year":"2017","unstructured":"Sandborn, W. J. et al. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis. N. Engl. J. Med. 376, 1723\u20131736 (2017).","journal-title":"N. Engl. J. Med."},{"key":"2345_CR469","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.cgh.2020.10.038","volume":"20","author":"WJ Sandborn","year":"2022","unstructured":"Sandborn, W. J. et al. Efficacy and Safety Of Extended Induction With Tofacitinib For The Treatment Of Ulcerative Colitis. Clin. Gastroenterol. Hepatol. 20, 1821\u20131830.e1823 (2022).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2345_CR470","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.cgh.2020.10.004","volume":"20","author":"JF Colombel","year":"2022","unstructured":"Colombel, J. F. et al. Maintenance of Remission With Tofacitinib Therapy In Patients With Ulcerative Colitis. Clin. Gastroenterol. Hepatol. 20, 116\u2013125.e115 (2022).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2345_CR471","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/ibd\/izad180","volume":"29","author":"CH Zinger","year":"2023","unstructured":"Zinger, C. H. et al. Upadacitinib for Acute Severe Ulcerative Colitis. Inflamm. Bowel Dis. 29, 1667\u20131669 (2023).","journal-title":"Inflamm. Bowel Dis."},{"key":"2345_CR472","first-page":"686","volume":"114","author":"G Rodr\u00edguez Toboso","year":"2022","unstructured":"Rodr\u00edguez Toboso, G. et al. Upadacitinib in refractory ulcerative colitis. Rev. Esp. Enferm. Dig. 114, 686\u2013688 (2022).","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"2345_CR473","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.cgh.2023.03.001","volume":"21","author":"S Friedberg","year":"2023","unstructured":"Friedberg, S. et al. Upadacitinib Is Effective And Safe In Both Ulcerative Colitis And Crohn\u2019s Disease: Prospective Real-world Experience. Clin. Gastroenterol. Hepatol. 21, 1913\u20131923.e1912 (2023).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2345_CR474","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/j.cgh.2022.11.029","volume":"21","author":"EV Loftus Jr.","year":"2023","unstructured":"Loftus, E. V. Jr. et al. Upadacitinib therapy reduces ulcerative colitis symptoms as early as day 1 of induction treatment. Clin. Gastroenterol. Hepatol. 21, 2347\u20132358.e2346 (2023).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2345_CR475","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1093\/ecco-jcc\/jjab099","volume":"15","author":"S Ghosh","year":"2021","unstructured":"Ghosh, S. et al. Upadacitinib treatment improves symptoms of bowel urgency and abdominal pain, and correlates with quality of life improvements in patients with moderate to severe ulcerative colitis. J. Crohns Colitis 15, 2022\u20132030 (2021).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR476","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0140-6736(22)00581-5","volume":"399","author":"S Danese","year":"2022","unstructured":"Danese, S. et al. Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials. Lancet 399, 2113\u20132128 (2022).","journal-title":"Lancet"},{"key":"2345_CR477","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1053\/j.gastro.2020.02.030","volume":"158","author":"WJ Sandborn","year":"2020","unstructured":"Sandborn, W. J. et al. Efficacy of upadacitinib in a randomized trial of patients with active ulcerative colitis. Gastroenterology 158, 2139\u20132149.e2114 (2020).","journal-title":"Gastroenterology"},{"key":"2345_CR478","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/ibd\/izad016","volume":"29","author":"S Danese","year":"2023","unstructured":"Danese, S. et al. Upadacitinib induction and maintenance therapy improves abdominal pain, bowel urgency, and fatigue in patients with ulcerative colitis: a post hoc analysis of phase 3 Data. Inflamm. Bowel Dis. 29, 1723\u20131729 (2023).","journal-title":"Inflamm. Bowel Dis."},{"key":"2345_CR479","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1093\/ibd\/izac260","volume":"29","author":"J Pan\u00e9s","year":"2023","unstructured":"Pan\u00e9s, J. et al. Induction and maintenance treatment with upadacitinib improves health-related quality of life in patients with moderately to severely active ulcerative colitis: phase 3 study results. Inflamm. Bowel Dis. 29, 1421\u20131430 (2023).","journal-title":"Inflamm. Bowel Dis."},{"key":"2345_CR480","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/apt.17816","volume":"59","author":"R Panaccione","year":"2024","unstructured":"Panaccione, R. et al. Efficacy and safety of upadacitinib for 16-week extended induction and 52-week maintenance therapy in patients with moderately to severely active ulcerative colitis. Aliment Pharm. Ther. 59, 393\u2013408 (2024).","journal-title":"Aliment Pharm. Ther."},{"key":"2345_CR481","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/ecco-jcc\/jjad123","volume":"18","author":"S Vermeire","year":"2024","unstructured":"Vermeire, S. et al. Withdrawal and Re-treatment with filgotinib in ulcerative colitis: post hoc analyses of the phase 2b\/3 selection and selectionlte studies. J. Crohns Colitis 18, 54\u201364 (2024).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR482","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/ecco-jcc\/jjac122","volume":"17","author":"EV Loftus","year":"2023","unstructured":"Loftus, E. V. et al. Corticosteroid-sparing effects of filgotinib in moderately to severely active ulcerative colitis: data from the phase 2b\/3 SELECTION Study. J. Crohns Colitis 17, 211\u2013220 (2023).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR483","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/apt.17674","volume":"58","author":"S Schreiber","year":"2023","unstructured":"Schreiber, S. et al. Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE. Aliment Pharm. Ther. 58, 874\u2013887 (2023).","journal-title":"Aliment Pharm. Ther."},{"key":"2345_CR484","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/S0140-6736(21)00666-8","volume":"397","author":"BG Feagan","year":"2021","unstructured":"Feagan, B. G. et al. Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b\/3 double-blind, randomised, placebo-controlled trial. Lancet 397, 2372\u20132384 (2021).","journal-title":"Lancet"},{"key":"2345_CR485","doi-asserted-by":"crossref","unstructured":"Watanabe, K. et al. Impact of concomitant thiopurine on the efficacy and safety of filgotinib in patients with ulcerative colitis: post hoc analysis of the phase 2b\/3 selection study. J. Crohns Colitis 18, 801\u2013811 (2023).","DOI":"10.1093\/ecco-jcc\/jjad201"},{"key":"2345_CR486","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/ecco-jcc\/jjad018","volume":"17","author":"S Schreiber","year":"2023","unstructured":"Schreiber, S. et al. Filgotinib improved health-related quality of life and led to comprehensive disease control in individuals with ulcerative colitis: data from the selection Trial. J. Crohns Colitis 17, 863\u2013875 (2023).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR487","doi-asserted-by":"publisher","first-page":"138","DOI":"10.14309\/ajg.0000000000001979","volume":"118","author":"S Danese","year":"2023","unstructured":"Danese, S. et al. Rapid and sustained symptom relief in patients with ulcerative colitis treated with Filgotinib: data from the phase 2b\/3 selection trial. Am. J. Gastroenterol. 118, 138\u2013147 (2023).","journal-title":"Am. J. Gastroenterol."},{"key":"2345_CR488","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1093\/ecco-jcc\/jjad039","volume":"17","author":"I Dotan","year":"2023","unstructured":"Dotan, I. et al. Efficacy of Filgotinib in patients with ulcerative colitis by line of therapy in the phase 2b\/3 selection trial. J. Crohns Colitis 17, 1207\u20131216 (2023).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR489","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s40262-022-01129-y","volume":"61","author":"F Namour","year":"2022","unstructured":"Namour, F., Anderson, K., Nelson, C. & Tasset, C. Filgotinib: a clinical pharmacology review. Clin. Pharmacokinet. 61, 819\u2013832 (2022).","journal-title":"Clin. Pharmacokinet."},{"key":"2345_CR490","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.2217\/imt-2023-0012","volume":"15","author":"J Hanzel","year":"2023","unstructured":"Hanzel, J., Ma, C. & Jairath, V. Mirikizumab for the treatment of moderate to severe ulcerative colitis. Immunotherapy 15, 1199\u20131208 (2023).","journal-title":"Immunotherapy"},{"key":"2345_CR491","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s40262-023-01281-z","volume":"62","author":"L Chua","year":"2023","unstructured":"Chua, L., Friedrich, S. & Zhang, X. C. Mirikizumab pharmacokinetics in patients with moderately to severely active ulcerative colitis: results from phase III LUCENT studies. Clin. Pharmacokinet. 62, 1479\u20131491 (2023).","journal-title":"Clin. Pharmacokinet."},{"key":"2345_CR492","doi-asserted-by":"publisher","first-page":"e00630","DOI":"10.14309\/ctg.0000000000000630","volume":"14","author":"T Johnson","year":"2023","unstructured":"Johnson, T. et al. Mirikizumab-induced transcriptome changes in ulcerative colitis patient biopsies at week 12 ARE MAINTAINED THROUGH WEek 52. Clin. Transl. Gastroenterol. 14, e00630 (2023).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"2345_CR493","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1053\/j.gastro.2019.08.043","volume":"158","author":"WJ Sandborn","year":"2020","unstructured":"Sandborn, W. J. et al. Efficacy and safety of Mirikizumab in a randomized Phase 2 study of patients with ulcerative colitis. Gastroenterology 158, 537\u2013549.e510 (2020).","journal-title":"Gastroenterology"},{"key":"2345_CR494","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1093\/ecco-jcc\/jjad050","volume":"17","author":"F Magro","year":"2023","unstructured":"Magro, F. et al. Resolving histological inflammation in ulcerative colitis with mirikizumab in the lucent induction and maintenance trial programmes. J. Crohns Colitis 17, 1457\u20131470 (2023).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR495","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1056\/NEJMoa2207940","volume":"388","author":"G D\u2019Haens","year":"2023","unstructured":"D\u2019Haens, G. et al. Mirikizumab as induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med. 388, 2444\u20132455 (2023).","journal-title":"N. Engl. J. Med."},{"key":"2345_CR496","doi-asserted-by":"crossref","unstructured":"Dubinsky, M. C. et al. Changes in health-related quality of life and associations with improvements in clinical efficacy: a phase 2 study of mirikizumab in patients with ulcerative colitis. BMJ Open Gastroenterol. 10, e001115 (2023).","DOI":"10.1136\/bmjgast-2023-001115"},{"key":"2345_CR497","doi-asserted-by":"publisher","first-page":"otac044","DOI":"10.1093\/crocol\/otac044","volume":"5","author":"MC Dubinsky","year":"2023","unstructured":"Dubinsky, M. C. et al. Clinical effect of Mirikizumab treatment on bowel urgency in patients with moderately to severely active ulcerative colitis and the clinical relevance of bowel urgency improvement for disease remission. Crohns Colitis 360 5, otac044 (2023).","journal-title":"Crohns Colitis 360"},{"key":"2345_CR498","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000578","volume":"14","author":"B Steere","year":"2023","unstructured":"Steere, B. et al. Mirikizumab regulates genes involved in ulcerative colitis disease activity and anti-TNF resistance: results from a phase 2 study. Clin. Transl. Gastroenterol. 14, e00578 (2023).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"2345_CR499","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.cgh.2021.03.028","volume":"20","author":"RS Dalal","year":"2022","unstructured":"Dalal, R. S. et al. Predictors and outcomes of ustekinumab dose intensification in ulcerative colitis: a multicenter cohort study. Clin. Gastroenterol. Hepatol. 20, 2399\u20132401.e2394 (2022).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2345_CR500","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/apt.17386","volume":"57","author":"C Taxonera","year":"2023","unstructured":"Taxonera, C., Olivares, D., L\u00f3pez-Garc\u00eda, O. N. & Alba, C. Meta-analysis: real-world effectiveness and safety of ustekinumab in patients with ulcerative colitis. Aliment Pharm. Ther. 57, 610\u2013619 (2023).","journal-title":"Aliment Pharm. Ther."},{"key":"2345_CR501","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/ecco-jcc\/jjae013","volume":"18","author":"S Ghosh","year":"2024","unstructured":"Ghosh, S. et al. Safety of Ustekinumab in inflammatory bowel disease: pooled safety analysis through 5 years in Crohn\u2019s disease and 4 Years in ulcerative colitis. J. Crohns Colitis 18, 1091\u20131101 (2024).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR502","doi-asserted-by":"publisher","first-page":"910","DOI":"10.14309\/ajg.0000000000002621","volume":"119","author":"W Afif","year":"2024","unstructured":"Afif, W. et al. Efficacy and safety of ustekinumab for ulcerative colitis through 4 Years: final results of the UNIFI long-term maintenance study. Am. J. Gastroenterol. 119, 910\u2013921 (2024).","journal-title":"Am. J. Gastroenterol."},{"key":"2345_CR503","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/14712598.2024.2309300","volume":"24","author":"A Tursi","year":"2024","unstructured":"Tursi, A. et al. Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study. Expert Opin. Biol. Ther. 24, 101\u2013109 (2024).","journal-title":"Expert Opin. Biol. Ther."},{"key":"2345_CR504","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/ibd\/izaa236","volume":"27","author":"WJ Sandborn","year":"2021","unstructured":"Sandborn, W. J. et al. Safety of Ustekinumab in inflammatory bowel disease: pooled safety analysis of results from phase 2\/3 Studies. Inflamm. Bowel Dis. 27, 994\u20131007 (2021).","journal-title":"Inflamm. Bowel Dis."},{"key":"2345_CR505","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1016\/j.cgh.2022.02.050","volume":"20","author":"S Danese","year":"2022","unstructured":"Danese, S. et al. Early symptomatic improvement after ustekinumab therapy in patients with ulcerative colitis: 16-Week data From the UNIFI Trial. Clin. Gastroenterol. Hepatol. 20, 2858\u20132867.e2855 (2022).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2345_CR506","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1093\/ecco-jcc\/jjac030","volume":"16","author":"MT Abreu","year":"2022","unstructured":"Abreu, M. T. et al. Efficacy and safety of maintenance ustekinumab for ulcerative colitis through 3 Years: UNIFI Long-term extension. J. Crohns Colitis 16, 1222\u20131234 (2022).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR507","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/apt.16388","volume":"53","author":"J Dhaliwal","year":"2021","unstructured":"Dhaliwal, J. et al. One-year outcomes with ustekinumab therapy in infliximab-refractory paediatric ulcerative colitis: a multicentre prospective study. Aliment Pharm. Ther. 53, 1300\u20131308 (2021).","journal-title":"Aliment Pharm. Ther."},{"key":"2345_CR508","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/apt.16609","volume":"54","author":"J Hanzel","year":"2021","unstructured":"Hanzel, J. et al. Population pharmacokinetics of subcutaneous infliximab CT-P13 in Crohn\u2019s disease and ulcerative colitis. Aliment Pharm. Ther. 54, 1309\u20131319 (2021).","journal-title":"Aliment Pharm. Ther."},{"key":"2345_CR509","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1056\/NEJMoa050516","volume":"353","author":"P Rutgeerts","year":"2005","unstructured":"Rutgeerts, P. et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med. 353, 2462\u20132476 (2005).","journal-title":"N. Engl. J. Med."},{"key":"2345_CR510","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1097\/01.MIB.0000435438.84365.f7","volume":"19","author":"OJ Adedokun","year":"2013","unstructured":"Adedokun, O. J. et al. Pharmacokinetics of infliximab in children with moderate-to-severe ulcerative colitis: results from a randomized, multicenter, open-label, phase 3 study. Inflamm. Bowel Dis. 19, 2753\u20132762 (2013).","journal-title":"Inflamm. Bowel Dis."},{"key":"2345_CR511","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1053\/j.gastro.2021.02.068","volume":"160","author":"S Schreiber","year":"2021","unstructured":"Schreiber, S. et al. Randomized controlled trial: subcutaneous vs intravenous infliximab CT-P13 maintenance in inflammatory bowel disease. Gastroenterology 160, 2340\u20132353 (2021).","journal-title":"Gastroenterology"},{"key":"2345_CR512","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12887-019-1739-5","volume":"19","author":"H Tajiri","year":"2019","unstructured":"Tajiri, H. et al. Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan. BMC Pediatr. 19, 351 (2019).","journal-title":"BMC Pediatr."},{"key":"2345_CR513","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.crohns.2010.09.004","volume":"5","author":"C Mortensen","year":"2011","unstructured":"Mortensen, C. et al. Treatment of acute ulcerative colitis with infliximab, a retrospective study from three Danish hospitals. J. Crohns Colitis 5, 28\u201333 (2011).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR514","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1215734","volume":"369","author":"BG Feagan","year":"2013","unstructured":"Feagan, B. G. et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med. 369, 699\u2013710 (2013).","journal-title":"N. Engl. J. Med."},{"key":"2345_CR515","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12876-020-01253-8","volume":"20","author":"C Allner","year":"2020","unstructured":"Allner, C. et al. Baseline levels of dynamic CD4(+) T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study. BMC Gastroenterol. 20, 103 (2020).","journal-title":"BMC Gastroenterol."},{"key":"2345_CR516","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/jcph.1307","volume":"59","author":"K Kobayashi","year":"2019","unstructured":"Kobayashi, K. et al. A phase 1, multiple-dose study of Vedolizumab in Japanese Patients With Ulcerative Colitis. J. Clin. Pharm. 59, 271\u2013279 (2019).","journal-title":"J. Clin. Pharm."},{"key":"2345_CR517","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/apt.15113","volume":"49","author":"MT Osterman","year":"2019","unstructured":"Osterman, M. T. et al. Vedolizumab exposure levels and clinical outcomes in ulcerative colitis: determining the potential for dose optimisation. Aliment Pharm. Ther. 49, 408\u2013418 (2019).","journal-title":"Aliment Pharm. Ther."},{"key":"2345_CR518","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1159\/000512235","volume":"102","author":"M Nagahori","year":"2021","unstructured":"Nagahori, M. et al. Week 2 Symptomatic Response with Vedolizumab as a predictive factor in Japanese Anti-TNF\u03b1-Naive patients with ulcerative colitis: a post hoc analysis of a randomized, placebo-controlled phase 3 Trial. Digestion 102, 742\u2013752 (2021).","journal-title":"Digestion"},{"key":"2345_CR519","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/ecco-jcc\/jjy149","volume":"13","author":"WJ Sandborn","year":"2019","unstructured":"Sandborn, W. J. et al. Deep remission with vedolizumab in patients with moderately to severely active ulcerative colitis: a GEMINI 1 post hoc analysis. J. Crohns Colitis 13, 172\u2013181 (2019).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR520","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/ecco-jcc\/jjac036","volume":"16","author":"JS Hyams","year":"2022","unstructured":"Hyams, J. S. et al. Pharmacokinetics, safety and efficacy of intravenous vedolizumab in paediatric patients with ulcerative colitis or Crohn\u2019s disease: results from the phase 2 HUBBLE study. J. Crohns Colitis 16, 1243\u20131254 (2022).","journal-title":"J. Crohns Colitis"},{"key":"2345_CR521","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/MEG.0000000000002759","volume":"36","author":"T Chhibba","year":"2024","unstructured":"Chhibba, T. et al. Comparing the efficacy of vedolizumab between males and females: a post-hoc analysis of GEMINI-1 and VARSITY. Eur. J. Gastroenterol. Hepatol. 36, 704\u2013711 (2024).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"2345_CR522","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/apt.16160","volume":"53","author":"S Danese","year":"2021","unstructured":"Danese, S. et al. Vedolizumab treatment persistence and safety in a 2-year data analysis of an extended access programme. Aliment Pharm. Ther. 53, 265\u2013272 (2021).","journal-title":"Aliment Pharm. Ther."},{"key":"2345_CR523","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.cgh.2023.10.029","volume":"22","author":"V Jairath","year":"2024","unstructured":"Jairath, V., et al. ENTERPRET: a randomized controlled trial of Vedolizumab dose optimization in patients with ulcerative colitis who have early nonresponse. Clin. Gastroenterol. Hepatol. 22, 1077\u20131086.e1013 (2024).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2345_CR524","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.116095","volume":"304","author":"P Wei","year":"2023","unstructured":"Wei, P. et al. Baitouweng decoction alleviates dextran sulfate sodium-induced ulcerative colitis by suppressing leucine-related mTORC1 signaling and reducing oxidative stress. J. Ethnopharmacol. 304, 116095 (2023).","journal-title":"J. Ethnopharmacol."},{"key":"2345_CR525","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/bab.2451","volume":"70","author":"W Ji","year":"2023","unstructured":"Ji, W. et al. Banxia Xiexin decoction ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis via inhibiting serine-threonine protein kinase (Akt)\/mitogen-activated protein kinase (MAPK) signaling pathway. Biotechnol. Appl. Biochem. 70, 1530\u20131542 (2023).","journal-title":"Biotechnol. Appl. Biochem."},{"key":"2345_CR526","doi-asserted-by":"publisher","first-page":"1083788","DOI":"10.3389\/fimmu.2022.1083788","volume":"13","author":"C Zhu","year":"2022","unstructured":"Zhu, C. et al. Berberine a traditional Chinese drug repurposing: its actions in inflammation-associated ulcerative colitis and cancer therapy. Front. Immunol. 13, 1083788 (2022).","journal-title":"Front. Immunol."},{"key":"2345_CR527","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/s41401-021-00781-7","volume":"43","author":"YY Li","year":"2022","unstructured":"Li, Y. Y. et al. Baicalein ameliorates ulcerative colitis by improving intestinal epithelial barrier via AhR\/IL-22 pathway in ILC3s. Acta Pharm. Sin. 43, 1495\u20131507 (2022).","journal-title":"Acta Pharm. Sin."},{"key":"2345_CR528","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2023.112630","volume":"167","author":"H Lu","year":"2023","unstructured":"Lu, H. et al. Alleviative effects of natural plant polysaccharides against DSS-induced ulcerative colitis via inhibiting inflammation and modulating gut microbiota. Food Res. Int. 167, 112630 (2023).","journal-title":"Food Res. Int."},{"key":"2345_CR529","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156708","volume":"141","author":"J Zhang","year":"2025","unstructured":"Zhang, J. et al. Scutellaria baicalensis extracts restrict intestinal epithelial cell ferroptosis by regulating lipid peroxidation and GPX4\/ACSL4 in Colitis. Phytomedicine 141, 156708 (2025).","journal-title":"Phytomedicine"},{"key":"2345_CR530","doi-asserted-by":"publisher","first-page":"118554","DOI":"10.1016\/j.jep.2024.118554","volume":"334","author":"J Shen","year":"2024","unstructured":"Shen, J., Zhao, Y. & Cui, W. Astragalus mongholicus Bunge extract improves ulcerative colitis by promoting PLCB2 to inhibit colonic epithelial cell pyroptosis. J. Ethnopharmacol. 334, 118554 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"2345_CR531","doi-asserted-by":"publisher","first-page":"529","DOI":"10.17219\/acem\/146234","volume":"31","author":"A Zhou","year":"2022","unstructured":"Zhou, A. et al. Dandelion root extracts abolish MAPK pathways to ameliorate experimental mouse ulcerative colitis. Adv. Clin. Exp. Med 31, 529\u2013538 (2022).","journal-title":"Adv. Clin. Exp. Med"},{"key":"2345_CR532","doi-asserted-by":"crossref","unstructured":"Yan, S., Yin, L. & Dong, R. Inhibition of IEC-6 cell proliferation and the mechanism of ulcerative colitis in C57BL\/6 Mice by Dandelion Root Polysaccharides. Foods. 12, 3800 (2023).","DOI":"10.3390\/foods12203800"},{"key":"2345_CR533","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6257778","volume":"2022","author":"C Huang","year":"2022","unstructured":"Huang, C. et al. Alkaloids from Aconitum carmichaelii Alleviates DSS-Induced ulcerative colitis in mice via MAPK\/NF-\u03baB\/STAT3 signaling inhibition. Evid. Based Complement Altern. Med. 2022, 6257778 (2022).","journal-title":"Evid. Based Complement Altern. Med."},{"key":"2345_CR534","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.jfma.2018.08.011","volume":"118","author":"JW Wang","year":"2019","unstructured":"Wang, J. W. et al. Fecal microbiota transplantation: review and update. J. Formos. Med. Assoc. 118, S23\u2013s31 (2019).","journal-title":"J. Formos. Med. Assoc."},{"key":"2345_CR535","doi-asserted-by":"publisher","first-page":"7495","DOI":"10.2147\/IDR.S385485","volume":"15","author":"XH Guo","year":"2022","unstructured":"Guo, X. H. et al. The effects of multi-donor fecal microbiota transplantation capsules combined with thalidomide on hormone-dependent ulcerative colitis. Infect. Drug Resist 15, 7495\u20137501 (2022).","journal-title":"Infect. Drug Resist"},{"key":"2345_CR536","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.818111","volume":"13","author":"WH Zhang","year":"2022","unstructured":"Zhang, W. H. et al. Fecal microbiota transplantation ameliorates active ulcerative colitis by downregulating pro-inflammatory cytokines in mucosa and serum. Front. Microbiol. 13, 818111 (2022).","journal-title":"Front. Microbiol."},{"key":"2345_CR537","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.683234","volume":"12","author":"F Zhu","year":"2021","unstructured":"Zhu, F. et al. Effects of different treatment of fecal microbiota transplantation techniques on treatment of ulcerative colitis in rats. Front. Microbiol. 12, 683234 (2021).","journal-title":"Front. Microbiol."},{"key":"2345_CR538","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12866-021-02325-9","volume":"21","author":"H Shimizu","year":"2021","unstructured":"Shimizu, H. et al. Stool preparation under anaerobic conditions contributes to retention of obligate anaerobes: potential improvement for fecal microbiota transplantation. BMC Microbiol. 21, 275 (2021).","journal-title":"BMC Microbiol."},{"key":"2345_CR539","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/jgh.16015","volume":"38","author":"J Yao","year":"2023","unstructured":"Yao, J., Fekadu, G., Ng, S. C. & You, J. H. S. Fecal microbiota transplantation for patients with active ulcerative colitis: a cost-effectiveness analysis. J. Gastroenterol. Hepatol. 38, 70\u201378 (2023).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2345_CR540","doi-asserted-by":"publisher","first-page":"e0215921","DOI":"10.1128\/spectrum.02159-21","volume":"11","author":"B Zhang","year":"2023","unstructured":"Zhang, B. et al. A matching strategy to guide donor selection for ulcerative colitis in fecal microbiota transplantation: meta-analysis and analytic hierarchy process. Microbiol. Spectr. 11, e0215921 (2023).","journal-title":"Microbiol. Spectr."},{"key":"2345_CR541","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12876-021-01856-9","volume":"21","author":"JW Crothers","year":"2021","unstructured":"Crothers, J. W. et al. Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study. BMC Gastroenterol. 21, 281 (2021).","journal-title":"BMC Gastroenterol."},{"key":"2345_CR542","doi-asserted-by":"publisher","first-page":"G970","DOI":"10.1152\/ajpgi.00183.2012","volume":"304","author":"A Fischer","year":"2013","unstructured":"Fischer, A. et al. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-alpha on tight junction proteins and signaling pathways in intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 304, G970\u2013G979 (2013).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2345_CR543","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41575-023-00768-1","volume":"20","author":"B Verstockt","year":"2023","unstructured":"Verstockt, B. et al. IL-12 and IL-23 pathway inhibition in inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 20, 433\u2013446 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2345_CR544","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/ibd\/izae112","volume":"31","author":"O Ledder","year":"2025","unstructured":"Ledder, O. et al. Tofacitinib in pediatric ulcerative colitis: a retrospective multicenter experience. Inflamm. Bowel Dis. 31, 425\u2013431 (2025).","journal-title":"Inflamm. Bowel Dis."},{"key":"2345_CR545","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1080\/14728222.2022.2084381","volume":"26","author":"YE Hernandez Santana","year":"2022","unstructured":"Hernandez Santana, Y. E., Irwin, N. & Walsh, P. T. IL-36: a therapeutic target for ulcerative colitis?. Expert Opin. Ther. Targets 26, 507\u2013512 (2022).","journal-title":"Expert Opin. Ther. Targets"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02345-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02345-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02345-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:03:30Z","timestamp":1770768210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02345-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":545,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2345"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02345-1","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}